About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Amlodipine Besylate
- Company
- XueQing Yu
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 25 recruiting
Efficacy results: Not yet reported
25 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 5, 2026
Find a Clinical Trial Near Me
See recruiting studies for Amlodipine Besylate and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02904291
Bariatric Surgery and Pharmacokinetics of Amlodipine
Norwegian University of Science and Technology 12 participants Est. completion 2026-05 1 siteOther conditions: Obesity, MorbidView official trial listing → -
Recruiting NCT NCT03264352
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
Not yet reported XueQing Yu 11414 participants Est. completion 2029-09-01 1 siteType 2 diabetes Other conditions: Adverse Event, Blood Pressure, Prehypertension, Cardiovascular Risk FactorView official trial listing → -
Recruiting NCT NCT04191681
Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study
Not yet reported The Cleveland Clinic 50 participants Est. completion 2022-12 1 site Stand-aloneHeart failureView official trial listing → -
Recruiting NCT NCT04974138
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 32000 participants Est. completion 2030-06-30 20 sites Stand-aloneOther conditions: Hypertension, MTHFR 677 CC or CT Genotype, Elevated Plasma Homocysteine (Hcy≥10µmol/L), Insufficient Plasma Folate Levels (<12ng/mL)View official trial listing → -
Recruiting NCT NCT04974151
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 24000 participants Est. completion 2029-06-30 20 sites Stand-aloneOther conditions: Hypertension, MTHFR 677 TT GenotypeView official trial listing → -
Recruiting NCT NCT05089448
Morning Versus Bedtime Dosing of Antihypertensive Medication
Not yet reported Yan Li 300 participants Est. completion 2026-09-30 1 site Stand-aloneOther conditions: Hypertension, Blood Pressure, Drug UseView official trial listing → -
Recruiting NCT NCT05155137
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
Not yet reported Hospital Moinhos de Vento 8518 participants Est. completion 2030-12-14 2 sites Stand-aloneCardiovascular disease Other conditions: Cognitive DeclineView official trial listing → -
Recruiting NCT NCT05293756
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Not yet reported Case Western Reserve University 208 participants Est. completion 2027-05-31 1 site Stand-aloneOther conditions: Hypertension, Self-Management, Technology, Quality of LifeView official trial listing → -
Recruiting NCT NCT05312892
Sympathetic Mechanisms in Obesity-Crossover Design
Not yet reported, Not yet reported Vanderbilt University Medical Center 12 participants Est. completion 2030-12-31 1 siteOther conditions: Obesity, HypertensionView official trial listing → -
Recruiting NCT NCT05413057
An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
Boryung Pharmaceutical Co., Ltd 20000 participants Est. completion 2026-06 1 siteOther conditions: Hypertension,EssentialView official trial listing → -
Recruiting NCT NCT05593055
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
Not yet reported Brigham and Women's Hospital 75 participants Est. completion 2027-12-31 1 siteOther conditions: Hypertension, Left Ventricular HypertrophyView official trial listing → -
Recruiting NCT NCT05660083
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Not yet reported The Methodist Hospital Research Institute 36 participants Est. completion 2028-12-02 3 sites Stand-aloneOther conditions: HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma, TNBC - Triple-Negative Breast CancerView official trial listing → -
Recruiting NCT NCT05780710
OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake
Not yet reported Aktiia SA 35 participants Est. completion 2026-12-31 3 sitesOther conditions: HypertensionView official trial listing → -
Recruiting NCT NCT06150560
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Not yet reported Mayo Clinic 120 participants Est. completion 2028-06-01 1 siteOther conditions: Coarctation of Aorta, High Blood PressureView official trial listing → -
Recruiting NCT NCT06424834
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Not yet reported, Not yet reported Stanford University 150 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Angina Pectoris, Microvascular Angina, Vasospastic Angina, Myocardial Bridge of Coronary ArteryView official trial listing → -
Recruiting NCT NCT06495710
Arterial Stiffness and Blood Pressure
Not yet reported VA Office of Research and Development 228 participants Est. completion 2028-12-31 3 sites Stand-aloneOther conditions: Hypertension, Vascular Stiffness, AgingView official trial listing → -
Recruiting NCT NCT06523465
Statin Combined with Amlodipine Treats Primary Aldosteronism
Not yet reported Third Military Medical University 180 participants Est. completion 2026-09-30 1 site Stand-aloneOther conditions: Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist, HypertensionView official trial listing → -
Recruiting NCT NCT06625346
Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.
The Searle Company Limited Pakistan 420 participants Est. completion 2025-09-15 2 sitesOther conditions: HypertensionView official trial listing → -
Recruiting NCT NCT06826872
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 252 participants Est. completion 2025-12-30 1 siteCardiovascular disease Other conditions: Hypertension, Essential, CardiologyView official trial listing → -
Recruiting NCT NCT07099677
Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk
Not yet reported Abant Izzet Baysal University 186 participants Est. completion 2026-06-30 1 site Stand-aloneOther conditions: Hypertension, Fall Risk, Postural Balance, Fear of FallingView official trial listing → -
Recruiting NCT NCT07259733
Rapid Management of Resistant Hypertension in the Public Health System (Fast Control)
Not yet reported Instituto Dante Pazzanese de Cardiologia 142 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Apparent Resistant Hypertension, Hypertension, High Blood PressureView official trial listing → -
Recruiting NCT NCT07458880
Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control
Not yet reported The University of Hong Kong 140 participants Est. completion 2030-06-30 4 sitesOther conditions: Intracerebral HemorrhageView official trial listing → -
Recruiting NCT NCT07679828
Polypills Approach for Multiple Cardiovascular Risk Factors
Not yet reported China Medical University, China 8252 participants Est. completion 2030-03-01 15 sites Stand-aloneOther conditions: Hypertension, Dyslipidemia, DiabetesView official trial listing → -
Recruiting NCT NCT07683585
Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention
Not yet reported National Medical Research Center for Therapy and Preventive Medicine 207 participants Est. completion 2026-09 1 siteOther conditions: Hypertension, Coronary Arterial Disease, Percutaneous Coronary InterventionView official trial listing → -
Recruiting NCT NCT07784296
Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension
Hanmi Pharmaceutical Company Limited 3500 participants Est. completion 2028-08-31 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00000522
Treatment of Mild Hypertension Study (TOMHS)
Not yet reported University of Minnesota Est. completion 1994-05Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Vascular DiseasesView official trial listing → -
Completed NCT NCT00000542
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2002-03Cardiovascular diseaseHeart failure Other conditions: Coronary Disease, Diabetes Mellitus, Heart Diseases, Hypercholesterolemia, Hypertension, Myocardial IschemiaView official trial listing → -
Completed NCT NCT00000620
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sitesCardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary DiseaseView official trial listing → -
Completed NCT NCT00006294
Genetics of Hypertension Associated Treatments (GenHAT)
Donna Arnett, 257-5678 37939 participants Est. completion 2005-08 1 siteCardiovascular disease Other conditions: Heart Diseases, Hypertension, Coronary DiseaseView official trial listing → -
Completed NCT NCT00015457
Amlodipine Plus Botulinum Toxin for Focal Dystonia
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 16 participants 1 site Stand-aloneOther conditions: Focal DystoniaView official trial listing → -
Completed NCT NCT00039975
Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2004-04 9 sitesCardiovascular disease Other conditions: HIV Infections, HypertensionView official trial listing → -
Completed NCT NCT00081731
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Not yet reported Baim Institute for Clinical Research 947 participants Est. completion 2013-09 1 siteCardiovascular disease Other conditions: Atherosclerosis, Hypertension, Renovascular, Renal Artery ObstructionView official trial listing → -
Completed NCT NCT00091429
Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine
Not yet reported Gilead Sciences 500 participants Est. completion 2005-02Other conditions: AnginaView official trial listing → -
Completed NCT NCT00124969
Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure
Not yet reported Charite University, Berlin, Germany 356 participants Est. completion 2006-10 1 siteOther conditions: Kidney Failure, ChronicView official trial listing → -
Status unknown NCT NCT00125463
Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
Not yet reported The Japanese Society of Hypertension 3200 participants Est. completion 2005-12 1 siteCardiovascular disease Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00129233
Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance
Not yet reported Nagoya University 1150 participants Est. completion 2013-04 1 siteType 2 diabetes Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00134160
OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
Not yet reported OSCAR Study 1000 participants Est. completion 2010-05 2 sitesCardiovascular disease Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00136773
Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
Not yet reported Novartis 332 participants Est. completion 2005-11Other conditions: AlbuminuriaView official trial listing → -
Completed NCT NCT00136851
Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
Not yet reported Novartis Pharmaceuticals 259 participants Est. completion 2005-07 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00139555
Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension
Not yet reported Novartis 125 participants Est. completion 2006-11 1 siteOther conditions: Hypertension, Left Ventricular HypertrophyView official trial listing → -
Completed NCT NCT00140959
Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)
Not yet reported Organon and Co 120 participants Est. completion 2004-06-30Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00140985
Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)
Not yet reported Organon and Co 97 participants Est. completion 2002-01Other conditions: Renal DisorderView official trial listing → -
Completed NCT NCT00142584
Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
Not yet reported Mylan Bertek Pharmaceuticals 336 participants Est. completion 2008-03 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00143195
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 200 participants Est. completion 2005-01 12 sitesOther conditions: Myocardial IschemiaView official trial listing → -
Completed NCT NCT00143234
Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1825 participants Est. completion 2005-07 118 sitesOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT00150384
Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2005-08 106 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Terminated NCT NCT00151619
Effects of Amlodipine in the Management of Chronic Heart Failure
Not yet reported Rennes University Hospital 7 participants 2 sitesHeart failureView official trial listing → -
Completed NCT NCT00156403
A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis
Not yet reported, Not yet reported University of Pittsburgh 8 participants Est. completion 2005-12 1 siteOther conditions: PancreatitisView official trial listing → -
Completed NCT NCT00157963
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
Not yet reported Organon and Co 174 participants Est. completion 2006-02-08Other conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00159692
Amlodipine Diabetic Hypertension Efficacy Response Trial
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 739 participants Est. completion 2005-08Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00159718
Double Blind Atorvastatin Amlodipine Study
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 360 participants Est. completion 2007-01 33 sitesOther conditions: AnginaView official trial listing → -
Completed NCT NCT00160212
Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
Not yet reported Solvay Pharmaceuticals 130 sitesOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00170950
Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension
Not yet reported Novartis 11506 participants Est. completion 2008-05 5 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00170963
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
Not yet reported Novartis 1018 participants Est. completion 2005-06 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00170976
A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
Not yet reported Novartis 403 participants Est. completion 2005-06 2 sitesOther conditions: HYPERTENSIONView official trial listing → -
Completed NCT NCT00171002
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone
Not yet reported Novartis 936 participants Est. completion 2005-06 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00171054
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
Not yet reported Novartis 125 participants Est. completion 2007-10 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00171366
A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
Not yet reported Novartis 1422 participants Est. completion 2005-07 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00171535
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
Not yet reported Novartis 130 participants Est. completion 2005-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00171561
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
Not yet reported Novartis 144 participants Est. completion 2006-09 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00174304
Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1120 participants Est. completion 2006-09 102 sitesOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT00174330
Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 330 participants Est. completion 2006-02 15 sitesOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT00185120
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
Not yet reported Daiichi Sankyo 152 participants Est. completion 2006-09 20 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00185133
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
Not yet reported Daiichi Sankyo 1900 participants Est. completion 2007-01 139 sitesOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00198562
Hypertension Control Based on Home Blood Pressure
Not yet reported Ministry of Health, Labour and Welfare, Japan 2600 participants Est. completion 2012-03 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00202618
Rationale and Design for Shiga Microalbuminuria Reduction Trial
Not yet reported Shiga University 160 participants Est. completion 2006-06 1 siteOther conditions: Hypertension, Diabetes Mellitus, AlbuminuriaView official trial listing → -
Completed NCT NCT00219076
A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients
Not yet reported Novartis 504 participants 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00219115
A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg
Not yet reported Novartis 493 participants Est. completion 2006-03 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00219154
A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine
Not yet reported Novartis 1125 participants Est. completion 2006-01 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00220220
Amlodipine as add-on to Olmesartan in Hypertension
Not yet reported Sankyo Pharma Gmbh 429 participants Est. completion 2007-04 6 sitesOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00220233
Olmesartan as an add-on to Amlodipine in Hypertension
Not yet reported Sankyo Pharma Gmbh 632 participants Est. completion 2007-08 5 sitesOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00224549
PHARES Study: Management of Resistant Hypertension
Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2009-08 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00231803
The Canadian Prevention of Renal and Cardiovascular Endpoints Trial
Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT00234871
Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)
Not yet reported Abbott 357 participantsOther conditions: Hypertension, Diabetes, ProteinuriaView official trial listing → -
Completed NCT NCT00237588
Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)
Not yet reported Ullevaal University Hospital 25 participants Est. completion 2005-07 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00240474
A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)
Not yet reported Boehringer Ingelheim 1000 participants Est. completion 2004-03 73 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00241150
Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
Not yet reported Novartis 80 participants Est. completion 2005-01Metabolic syndrome Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00242814
Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
Not yet reported Boehringer Ingelheim 100 participants 31 sitesMetabolic syndrome Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00264212
AMISH : Aprovel for Management of Isolated Systolic Hypertension
Not yet reported Sanofi 436 participants 8 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00281580
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
Not yet reported Boehringer Ingelheim 1461 participants 136 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00289406
Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension
Not yet reported SK Chemicals Co., Ltd. 110 participants Est. completion 2006-02 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00294567
Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
Not yet reported Juntendo University 199 participants Est. completion 2011-01 1 siteOther conditions: Hypertension, Coronary AtherosclerosisView official trial listing → -
Completed NCT NCT00294710
A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
Not yet reported Novartis 976 participants Est. completion 2006-07 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00304226
Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
Not yet reported Novartis 1288 participants Est. completion 2007-01 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00311155
Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension
Not yet reported Sankyo Pharma Gmbh 694 participants Est. completion 2008-04 79 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Terminated NCT NCT00313547
High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients
Not yet reported Montreal Heart Institute 40 participants Est. completion 2008-03 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00327145
A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy
Not yet reported Novartis 894 participants Est. completion 2007-01 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00327587
8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
Not yet reported Novartis 2279 participants Est. completion 2007-08 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00330785
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1250 participants Est. completion 2005-09 126 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00332761
Caduet in an Untreated Subject Population
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2007-09 34 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00333489
Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
Not yet reported Novartis 551 participants Est. completion 2005-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00337298
The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes
Not yet reported University of Aarhus 25 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: Type 1 Diabetes, Diabetic Retinopathy, Eye Diseases, Diabetes ComplicationsView official trial listing → -
Completed NCT NCT00338338
The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients
Not yet reported GlaxoSmithKline 70 participants Est. completion 2007-09-14 1 siteOther conditions: Uncomplicated Hypertension, Hypertension, EssentialView official trial listing → -
Completed NCT NCT00350168
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
Not yet reported Novartis 647 participants Est. completion 2007-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00351130
Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
Not yet reported Novartis 79 participants Est. completion 2007-03 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00353912
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
Not yet reported Novartis 571 participants Est. completion 2007-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00360178
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
Not yet reported Novartis 198 participants Est. completion 2006-12 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00367939
Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
Not yet reported Novartis 132 participants Est. completion 2006-07 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00367978
Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus
Not yet reported Novartis 275 participants Est. completion 2003-09 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00368277
A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
Not yet reported Novartis Pharmaceuticals 901 participants Est. completion 2008-02 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00382421
Study to Investigate Effects of Antiischemic Drug Therapy in Silent Ischemia
Not yet reported Luzerner Kantonsspital Est. completion 2006-04 1 siteOther conditions: Myocardial IschemiaView official trial listing → -
Completed NCT NCT00392262
A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
Not yet reported Novartis 224 participants Est. completion 2007-02 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00400777
Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
Not yet reported Novartis 460 participants Est. completion 2008-06 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00402103
An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure
Not yet reported Novartis 556 participants Est. completion 2008-04 8 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00407537
Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1531 participants Est. completion 2009-10 125 sites Stand-aloneOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00409643
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
Not yet reported Novartis 1259 participants Est. completion 2004-07 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00409760
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.
Not yet reported Novartis 1930 participants Est. completion 2004-02 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00409851
One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
Not yet reported Novartis 1293 participants Est. completion 2005-03 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00412113
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 245 participants Est. completion 2008-04 51 sites Stand-aloneOther conditions: Dyslipidemia, HypertensionView official trial listing → -
Completed NCT NCT00413049
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
Not yet reported Novartis 698 participants Est. completion 2007-11 12 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00413413
Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
Not yet reported Novartis Pharmaceuticals 1134 participants Est. completion 2007-11 19 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00415623
A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 305 participants Est. completion 2007-10 14 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00417170
Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome
Not yet reported Novartis Pharmaceuticals 48 participants Est. completion 2010-07 1 site Stand-aloneMetabolic syndrome Other conditions: High Blood Pressure, Insulin Resistance, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT00421863
Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study
Not yet reported Heart Care Foundation 1111 participants Est. completion 2009-01 45 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00425373
Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
Not yet reported, Not yet reported Novartis Pharmaceuticals 1474 participants Est. completion 2008-03 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00425997
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
Not yet reported Novartis 480 participants Est. completion 2007-10 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00426478
Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
Not yet reported Novartis 80 participants Est. completion 2007-09 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00437645
Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
Not yet reported Novartis Pharmaceuticals 1183 participants Est. completion 2007-11 12 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00438113
Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
Not yet reported Nova Scotia Health Authority 184 participants Est. completion 2016-09 1 siteOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT00439738
Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
Not yet reported Novartis Pharmaceuticals 412 participants 5 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00443456
Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
Not yet reported Pfizer 134 participants Est. completion 2008-06 9 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00446524
Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
Not yet reported Novartis 403 participants Est. completion 2008-10 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00446563
Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
Not yet reported Novartis 90 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Hypertension; Hypertrophy, Left VentricularView official trial listing → -
Completed NCT NCT00454662
Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
Not yet reported COLM Study Research Organization 5141 participants Est. completion 2011-09 1 siteCardiovascular disease Other conditions: Hypertension, DiabetesView official trial listing → -
Completed NCT NCT00460915
Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years
Not yet reported Korea University Guro Hospital 204 participants Est. completion 2010-02 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00492128
Kanagawa Combination Anti-hypertensive Therapy (K-CAT)
Not yet reported Yokohama City University Medical Center 196 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00498433
Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension
Not yet reported Novartis 46 participants Est. completion 2012-03 2 sites Stand-aloneOther conditions: Hypertension, Abdominal ObesityView official trial listing → -
Completed NCT NCT00509470
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
Not yet reported Tokyo University 75 participants Est. completion 2012-10 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00518479
Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression
Not yet reported University of Leeds 42 participants Est. completion 2004-04 1 site Stand-aloneOther conditions: Hypertension, Left Ventricular HypertrophyView official trial listing → -
Completed NCT NCT00523549
The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction
Not yet reported Novartis Pharmaceuticals 229 participants Est. completion 2008-01 1 site Stand-aloneOther conditions: Hypertension, Diastolic DysfunctionView official trial listing → -
Completed NCT NCT00523744
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
Not yet reported Novartis 257 participants Est. completion 2007-12 2 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00527514
Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
Not yet reported Daiichi Sankyo 185 participants Est. completion 2008-04 18 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00530946
A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 165 participants Est. completion 2008-04 17 sitesOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00535925
Nephropathy In Type 2 Diabetes and Cardio-renal Events
Not yet reported University of Campania Luigi Vanvitelli 850 participants Est. completion 2019-05 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT00538486
A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Not yet reported Third Military Medical University 360 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: Hypertension, ObesityView official trial listing → -
Terminated NCT NCT00542269
Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
Not yet reported Novartis 178 participants Est. completion 2009-07 1 site Stand-aloneMetabolic syndromeView official trial listing → -
Completed NCT NCT00548067
Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
Not yet reported Novartis 111 participants Est. completion 2008-03 5 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00550953
Filtered Trial for Telmisartan 40mg Non-responder
Not yet reported Boehringer Ingelheim 314 participants 5 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00553267
Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Not yet reported Boehringer Ingelheim 947 participants 97 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00558064
Filtered Trial for Amlodipine Non-responder
Not yet reported Boehringer Ingelheim 531 participants 41 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00558428
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
Not yet reported Boehringer Ingelheim 1098 participants 129 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00563901
Analyzing How Genetics May Affect Response to High Blood Pressure Medications
University of Alabama at Birmingham 37939 participants Est. completion 2004-05 2 sitesOther conditions: Hypertension, Coronary Disease, Cerebrovascular AccidentView official trial listing → -
Completed NCT NCT00568178
An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))
Not yet reported Organon and Co 306 participants Est. completion 2011-03-01 Stand-aloneOther conditions: ProteinuriaView official trial listing → -
Terminated NCT NCT00579254
Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 112 participants Est. completion 2008-05Other conditions: Hypertension and Cardiovascular Risk FactorsView official trial listing → -
Completed NCT NCT00591266
Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
Not yet reported Takeda 566 participants Est. completion 2009-04 50 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00601302
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
Not yet reported Roxane Laboratories 40 participants Est. completion 2004-05 1 siteOther conditions: Hypertension, Chronic Stable Angina, Vasospastic AnginaView official trial listing → -
Completed NCT NCT00602017
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
Not yet reported Roxane Laboratories 40 participants Est. completion 2004-05 1 siteOther conditions: Hypertension, Chronic Stable Angina, Vasospastic AnginaView official trial listing → -
Completed NCT NCT00614380
Open Label Study Telmisartan and Amlodipine in Hypertension
Not yet reported Boehringer Ingelheim 976 participants 122 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00618774
An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
Not yet reported Boehringer Ingelheim 259 participants 7 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00624052
26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
Not yet reported Boehringer Ingelheim 838 participants 92 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00626743
Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine
Not yet reported SK Chemicals Co., Ltd. 13 participants Est. completion 2011-07 2 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00627952
A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients
Not yet reported University of Erlangen-Nürnberg Medical School 100 participants Est. completion 2008-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00631514
Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Not yet reported University of Split 88 participants Est. completion 2006-09 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00637078
STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)
Not yet reported University of Western Ontario, Canada 1000 participants Est. completion 2010-12 1 siteOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00649389
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
Not yet reported Daiichi Sankyo 2500 participants Est. completion 2009-12 232 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00649402
Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg
Not yet reported Mylan Pharmaceuticals Inc 64 participants Est. completion 2004-06 1 site Stand-aloneOther conditions: HealhtyView official trial listing → -
Completed NCT NCT00649519
Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg
Not yet reported Mylan Pharmaceuticals Inc 54 participants Est. completion 2004-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00654745
18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics
Not yet reported Daiichi Sankyo 207 participants Est. completion 2009-06 21 sites Stand-aloneType 2 diabetes Other conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT00656331
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
Not yet reported University of New Mexico Est. completion 2012-06 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00659451
Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular
Not yet reported University of Pavia 100 participants Est. completion 2009-04 1 siteOther conditions: Essential Hypertension, Diabetes MellitusView official trial listing → -
Completed NCT NCT00661895
Black Education and Treatment of Hypertension (BEAT HTN)
Not yet reported Creighton University 99 participants Est. completion 2009-11 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00666536
The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy
Not yet reported Novartis 728 participants 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00667719
A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension
Not yet reported Novartis 564 participants Est. completion 2009-10-05 8 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT00669435
Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis
Not yet reported University of Pavia 75 participants Est. completion 2009-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00684489
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension
Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00687973
Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg
Not yet reported Novartis Pharmaceuticals 393 participants Est. completion 2009-01 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00693199
Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension
Not yet reported Anhui Medical University 360 participants Est. completion 2006-10 1 site Stand-aloneOther conditions: Lower Urinary Tract Symptoms, HypertensionView official trial listing → -
Completed NCT NCT00699192
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Not yet reported Novartis Pharmaceuticals 965 participants Est. completion 2009-05 18 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00700271
Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day
Not yet reported Novartis Pharmaceuticals 478 participants Est. completion 2008-08 2 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00716950
Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients
Not yet reported University of Pavia 187 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00739596
Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans
Not yet reported Novartis Pharmaceuticals 332 participants Est. completion 2009-03 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00739973
Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
Not yet reported Novartis Pharmaceuticals 2694 participants Est. completion 2009-05 18 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00741078
Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension
Not yet reported Gachon University Gil Medical Center Est. completion 2008-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00741585
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sitesCardiovascular diseaseChronic kidney disease Other conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00744237
Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients
Not yet reported Forest Laboratories 231 participants 65 sites Stand-aloneType 2 diabetes Other conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT00745953
Regression of Fatty Heart by Valsartan Therapy
Not yet reported University of Texas Southwestern Medical Center Est. completion 2009-08 1 siteMetabolic syndrome Other conditions: LipotoxicityView official trial listing → -
Completed NCT NCT00754429
The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)
Not yet reported Taipei Veterans General Hospital, Taiwan 40 participants Est. completion 2009-07Cardiovascular diseaseView official trial listing → -
Completed NCT NCT00760266
Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population
Not yet reported Novartis 451 participants Est. completion 2009-04 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00765674
Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension
Not yet reported Novartis 1191 participants Est. completion 2009-08 12 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00765947
Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension
Not yet reported Novartis 256 participants Est. completion 2009-08 4 sites Stand-aloneOther conditions: Essential Hypertension ( Mild to Moderate)View official trial listing → -
Completed NCT NCT00772499
Vascular Improvement With Olmesartan Medoxomil Study
Not yet reported Daiichi Sankyo 100 participants Est. completion 2005-07 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00775151
Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions
Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2005-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00775905
Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions
Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2005-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00777946
Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone
Not yet reported Novartis 818 participants Est. completion 2009-05 9 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00778921
Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone
Not yet reported Novartis 847 participants Est. completion 2009-06 7 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00787605
Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus
Not yet reported Novartis 860 participants Est. completion 2010-01 1 siteOther conditions: Hypertension, Diabetes MellitusView official trial listing → -
Completed NCT NCT00789321
A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 47 participants Est. completion 2009-03 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00791258
A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
Not yet reported Daiichi Sankyo 999 participants Est. completion 2009-09 72 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00797862
Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension
Not yet reported Novartis 1254 participants Est. completion 2010-11 10 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00805311
Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis
Not yet reported Russian Cardiology Research and Production Center 400 participants Est. completion 2014-05 2 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery Stenosis, AtherosclerosisView official trial listing → -
Status unknown NCT NCT00813722
Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment
Not yet reported University of Sao Paulo 400 participants Est. completion 2009-06 2 sitesOther conditions: Blood PressureView official trial listing → -
Completed NCT NCT00818779
Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
Not yet reported Texas Tech University Health Sciences Center 38 participants Est. completion 2011-08 1 siteCardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT00819104
A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
Not yet reported AstraZeneca 402 participants Est. completion 2009-08 11 sites Stand-aloneOther conditions: Primary HypertensionView official trial listing → -
Terminated NCT NCT00825188
A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives
Not yet reported University of Mississippi Medical Center 10 participants Est. completion 2014-03 1 siteOther conditions: Obesity, HypertensionView official trial listing → -
Completed NCT NCT00834600
Renin Profiling in Selection of Initial Antihypertensive Drug
Not yet reported The Louis & Rachel Rudin Foundation 185 participants Est. completion 2011-10 5 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00834977
Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 48 participants Est. completion 2004-05 2 sites Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00835367
Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions
Not yet reported Teva Pharmaceuticals USA 68 participants Est. completion 2004-03 2 sites Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00841542
Amlodipine 10 mg Tablets Under Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 28 participants Est. completion 2003-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00841672
Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension
Not yet reported Novartis 485 participants Est. completion 2009-09 6 sites Stand-aloneOther conditions: Moderate to Severe HypertensionView official trial listing → -
Completed NCT NCT00841815
Amlodipine 10 mg Tablets Under Fed Conditions
Not yet reported Teva Pharmaceuticals USA 28 participants Est. completion 2003-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00847262
Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes
Not yet reported Third Military Medical University 120 participants Est. completion 2009-06 1 siteOther conditions: Hypertension, Obesity, DiabetesView official trial listing → -
Completed NCT NCT00853957
Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension
Not yet reported Novartis 443 participants Est. completion 2009-08 9 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00860262
Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
Not yet reported Boehringer Ingelheim 858 participants 137 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00867490
Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension
Not yet reported Novartis 186 participants Est. completion 2009-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00870142
A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions
Not yet reported Actavis Inc. 26 participants Est. completion 2005-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00870571
A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions
Not yet reported Actavis Inc. 26 participants Est. completion 2005-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00877929
Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus
Not yet reported Boehringer Ingelheim 706 participants 65 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00890591
Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension
Not yet reported Daiichi Sankyo 144 participants Est. completion 2007-08 Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00891267
Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 60 participants Est. completion 2011-05 1 siteMetabolic syndrome Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00902304
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
Not yet reported Novartis Pharmaceuticals 2337 participants Est. completion 2011-07 3 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00902538
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
Not yet reported Daiichi Sankyo 2204 participants Est. completion 2010-10 117 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00921570
The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
Not yet reported Gulhane School of Medicine 105 participants Est. completion 2009-05 1 site Stand-aloneOther conditions: Diabetes, Hypertension, ProteinuriaView official trial listing → -
Completed NCT NCT00923091
Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension
Not yet reported Daiichi Sankyo 2689 participants Est. completion 2011-03 133 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00931710
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
Not yet reported Novartis 488 participants Est. completion 2010-01 1 site Stand-aloneOther conditions: Stage 2 Systolic HypertensionView official trial listing → -
Completed NCT NCT00932763
Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects
Not yet reported Torrent Pharmaceuticals Limited 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00932880
Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 18 Fed, Healthy Adult Subjects
Not yet reported Torrent Pharmaceuticals Limited 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT00935805
Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy
Hospital de Clinicas de Porto Alegre 124 participants Est. completion 2012-07 1 siteOther conditions: Diabetes Mellitus, Arterial HypertensionView official trial listing → -
Completed NCT NCT00938197
A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers
Not yet reported Boryung Pharmaceutical Co., Ltd 34 participants Est. completion 2009-08 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00940667
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
Not yet reported Hanmi Pharmaceutical Company Limited 185 participants Est. completion 2008-12 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00940680
Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
Not yet reported Hanmi Pharmaceutical Company Limited 142 participants Est. completion 2008-11 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00942344
Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension
Not yet reported Hanmi Pharmaceutical Company Limited 320 participants Est. completion 2007-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00942994
Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension
Not yet reported Novartis 412 participants 5 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00950066
Irbesartan and Amlodipine Combination in Controlling Blood Pressure
Not yet reported Sanofi 270 participants Est. completion 2010-01 4 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00956644
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
Not yet reported Sanofi 406 participants Est. completion 2010-08 40 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00957554
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
Not yet reported Sanofi 435 participants Est. completion 2010-09 38 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT00987662
Irbesartan Versus Amlodipine: The OBI Study
Not yet reported Aristotle University Of Thessaloniki Est. completion 2014-01 1 siteOther conditions: Obesity, HypertensionView official trial listing → -
Withdrawn NCT NCT00994253
Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics
Not yet reported Corewell Health East Est. completion 2012-12 1 site Stand-aloneOther conditions: Hypertension, Diabetes Type 2View official trial listing → -
Completed NCT NCT01001572
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
Not yet reported Novartis 932 participants Est. completion 2010-05 2 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01004614
Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 48 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT01011660
Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 13542 participants Est. completion 2012-12 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01030081
Amlodipine Prevents Morning Blood Pressure Surge Study
Not yet reported Shanghai Jiao Tong University School of Medicine 510 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01030458
Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial
Not yet reported KU Leuven 183 participants Est. completion 2012-03 7 sites Stand-aloneOther conditions: Blood PressureView official trial listing → -
Completed NCT NCT01041807
Cozaar XQ Re-examination Study (MK-0954-349)
Organon and Co 669 participants Est. completion 2015-03Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01048047
Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients
Not yet reported University of Pavia 88 participants Est. completion 2010-03 2 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01070030
Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension
Not yet reported Novartis 230 participants Est. completion 2010-10 3 sitesOther conditions: Stage II HypertensionView official trial listing → -
Completed NCT NCT01070043
To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
Not yet reported Novartis 60 participants Est. completion 2010-09 1 site Stand-aloneOther conditions: Hypertension, High Blood PressureView official trial listing → -
Terminated NCT NCT01080768
Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension
Not yet reported Novartis Pharmaceuticals 31 participants Est. completion 2010-11 9 sites Stand-aloneOther conditions: Hypertension, Ankle EdemaView official trial listing → -
Completed NCT NCT01083017
Resistant Arterial Hypertension Cohort Study
University Hospital, Geneva 74 participants Est. completion 2017-05 3 sitesOther conditions: Hypertension, Essential Hypertension, Resistant HypertensionView official trial listing → -
Withdrawn NCT NCT01089452
Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study
Not yet reported Monash University 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01091753
Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers
Not yet reported Yonsei University 28 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01101009
Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure
Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 486 participants Est. completion 2012-12 15 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01103960
An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy
Not yet reported Boehringer Ingelheim 324 participants 16 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01107743
Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1291 participants Est. completion 2012-04Other conditions: Hypertension, Angina Pectoris, Hypercholesterolemia, Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT01113047
Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine
Not yet reported Novartis 347 participants 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01117038
Drug Interaction Study of Avanafil and Enalapril or Amlodipine
Not yet reported VIVUS LLC 48 participants Est. completion 2010-05 1 site Stand-aloneOther conditions: Erectile DysfunctionView official trial listing → -
Completed NCT NCT01118520
AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)
Not yet reported Imperial College London 224 participants Est. completion 2015-04 9 sitesOther conditions: Abdominal Aortic AneurysmView official trial listing → -
Completed NCT NCT01120327
A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients
Not yet reported Seoul National University Hospital 211 participants Est. completion 2014-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01125254
Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major
Not yet reported, Not yet reported University of Campinas, Brazil 10 participants Est. completion 2011-07 1 site Stand-aloneOther conditions: Thalassemia MajorView official trial listing → -
Completed NCT NCT01127217
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
Not yet reported Hanmi Pharmaceutical Company Limited 149 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01128322
CKD-828 Primary Hypertension Trial(Dose-selection)
Not yet reported Chong Kun Dang Pharmaceutical 430 participants Est. completion 2011-03 26 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01130168
The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 38 participants Est. completion 2010-11 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01131546
Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension
Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 1080 participants Est. completion 2011-03 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01131923
Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 26 participants Est. completion 2002-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01131936
Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions
Not yet reported Dr. Reddy's Laboratories Limited 24 participants Est. completion 2002-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01134393
TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch
Not yet reported Boehringer Ingelheim 502 participants 47 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01138826
Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 18 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01155895
Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 54 participants Est. completion 2004-04 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01155908
Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions
Not yet reported Dr. Reddy's Laboratories Limited 48 participants Est. completion 2005-05 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01167153
Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients
Not yet reported Novartis 564 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01176032
ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling
Not yet reported Novartis Pharmaceuticals 74 participants Est. completion 2013-04 25 sites Stand-aloneOther conditions: Hypertension, Left Ventricle HypertrophyView official trial listing → -
Completed NCT NCT01177293
Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 14 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT01180205
Telmisartan, Amlodipine and Flow Mediated Dilation
Not yet reported Johannes Gutenberg University Mainz 576 participants Est. completion 2011-10 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01180413
Intensive Vasodilator Therapy in Patients With Essential Hypertension
Not yet reported Aarhus University Hospital 48 participants Est. completion 2012-04 1 site Stand-aloneOther conditions: Essential Hypertension, High Blood PressureView official trial listing → -
Completed NCT NCT01181011
Telmisartan, Amlodipine and Combination in Healthy Subjects
Not yet reported Boehringer Ingelheim 28 participants 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01190007
Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 159 participants Est. completion 2012-02 20 sitesOther conditions: Hypertension, Hypercholesterolemia, Angina PectorisView official trial listing → -
Completed NCT NCT01197001
A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2010-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01197014
A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01198249
Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension
Not yet reported Yonsei University 23 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT01198496
Recurrent Stroke Prevention Clinical Outcome Study
Not yet reported Biomedis International Ltd. 5000 participants Est. completion 2019-12 1 site Stand-aloneCardiovascular disease Other conditions: Hypertension, Blood PressureView official trial listing → -
Terminated NCT NCT01200407
Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients
Pfizer 615 participants Est. completion 2014-01-04 51 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01203696
Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease
Not yet reported Ruttonjee Hospital 97 participants Est. completion 2011-04 1 siteOther conditions: Ischemic Heart DiseaseView official trial listing → -
Completed NCT NCT01204398
Telmisartan+Amlodipine Fixed Dose Combination in Hypertension
Not yet reported Boehringer Ingelheim 27 participants 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01222520
Telmisartan 80mg Non-responder Trial
Not yet reported Boehringer Ingelheim 174 participants 4 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01237223
Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
Not yet reported Novartis 1342 participants Est. completion 2011-05 11 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01237873
Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension
Not yet reported Novartis Pharmaceuticals 150 participants Est. completion 2012-02 13 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01241487
A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy
Not yet reported Novartis 150 participants Est. completion 2011-01 1 site Stand-aloneOther conditions: Primary HypertensionView official trial listing → -
Completed NCT NCT01243268
A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
Boehringer Ingelheim 674 participants Est. completion 2016-08-18 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01246193
CKD-828(80/2.5mg) Pharmacokinetic Study
Not yet reported Chong Kun Dang Pharmaceutical 65 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT01252238
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2012-12 1 siteOther conditions: Insulin Sensitivity, Aortic Compliance, Diastolic FunctionView official trial listing → -
Completed NCT NCT01252563
Amlodipine 10mg Drug Use Investigation
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 14141 participants Est. completion 2012-10Other conditions: HypertensionView official trial listing → -
Completed NCT NCT01255475
Blood Pressure Reduction in Heart Failure
Not yet reported, Not yet reported University of Sao Paulo 21 participants Est. completion 2013-01 1 site Stand-aloneHeart failure Other conditions: Cardiac FailureView official trial listing → -
Completed NCT NCT01256411
A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
Not yet reported Novartis Pharmaceuticals 341 participants Est. completion 2012-04 33 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Terminated NCT NCT01259297
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People
Not yet reported Novartis Pharmaceuticals 2336 participants Est. completion 2012-11 185 sites Stand-aloneOther conditions: Cardiovascular EventsView official trial listing → -
Completed NCT NCT01264692
Essential Hypertension
Not yet reported Idorsia Pharmaceuticals Ltd. 196 participants Est. completion 2012-02 18 sitesOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT01271374
Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome
Not yet reported InVasc Therapeutics, Inc. 80 participants Est. completion 2011-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01277822
Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)
Not yet reported Organon and Co 334 participants Est. completion 2013-04-22 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01278797
Telmisartan and Amlodipine Versus Monocomponent Tablets
Not yet reported Boehringer Ingelheim 28 participants 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01280266
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon
Not yet reported, Not yet reported Seoul National University Hospital 29 participants Est. completion 2011-06 1 site Stand-aloneAlcohol use disorderView official trial listing → -
Completed NCT NCT01286558
Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)
Not yet reported Boehringer Ingelheim 225 participants 8 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01302691
MK-0954E Study in Participants With Hypertension (MK-0954E-357)
Not yet reported Merck Sharp & Dohme LLC 327 participants Est. completion 2012-04-01 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01316419
Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension
Boehringer Ingelheim 2089 participants Est. completion 2014-06 55 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01337674
Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)
Not yet reported Merck Sharp & Dohme LLC 26 participants Est. completion 2011-11-01 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01340131
CKD-828 (40/5mg) Pharmacokinetic Study
Not yet reported Chong Kun Dang Pharmaceutical 68 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01341392
Drug-drug Interaction Study(CKD-501, Amlodipine)
Not yet reported Chong Kun Dang Pharmaceutical 25 participants Est. completion 2011-08 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01344629
Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use
Not yet reported Boehringer Ingelheim 64 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01352689
CKD-828(80/2.5mg) Pharmacokinetic Study_2nd
Not yet reported Chong Kun Dang Pharmaceutical 67 participants Est. completion 2011-05 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01353274
Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension
Boehringer Ingelheim 1157 participants Est. completion 2013-08 254 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01354613
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
Not yet reported University of Wisconsin, Madison 14 participants Est. completion 2013-12 1 site Stand-aloneHeart failure Other conditions: Pulmonary Disease, Left Ventricular Hypertrophy/HypertensionView official trial listing → -
Completed NCT NCT01356017
CKD-828 Drug Interaction Study (Telmisartan)
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2011-09 1 site Stand-aloneOther conditions: Healthy Male VolunteersView official trial listing → -
Completed NCT NCT01356043
CKD-828 Drug Interaction Study (S-amlodipine)
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2011-08 1 site Stand-aloneOther conditions: Healthy Male VolunteersView official trial listing → -
Completed NCT NCT01365481
Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
Not yet reported Novartis Pharmaceuticals 150 participants Est. completion 2015-09 28 sites Stand-aloneChronic kidney disease Other conditions: HypertensionView official trial listing → -
Terminated NCT NCT01368536
Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
Not yet reported Novartis Pharmaceuticals 975 participants Est. completion 2012-02 97 sites Stand-aloneOther conditions: Hypertension, Stage 2 Hypertension, DiabetesView official trial listing → -
Completed NCT NCT01375322
ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria
Not yet reported TSH Biopharm Corporation Limited 226 participants Est. completion 2010-06 4 sites Stand-aloneType 2 diabetes Other conditions: Hypertension, AlbuminuriaView official trial listing → -
Status unknown NCT NCT01394770
Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients
Not yet reported University of Campania Luigi Vanvitelli 350 participants Est. completion 2012-09 1 site Stand-aloneOther conditions: Hypertension, DialysisView official trial listing → -
Completed NCT NCT01395199
Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major
Not yet reported University of Campinas, Brazil 62 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: Thalassemia, Iron OverloadView official trial listing → -
Withdrawn NCT NCT01409408
Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan
Not yet reported Hospital Universitario Pedro Ernesto Est. completion 2013-12 1 siteOther conditions: Hypertension, Diabetes MellitusView official trial listing → -
Terminated NCT NCT01425242
Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension
Not yet reported Amsterdam UMC, location VUmc 3 participants Est. completion 2013-12 1 siteOther conditions: Hypertension, Abdominal Aortic AneurysmView official trial listing → -
Completed NCT NCT01426100
CKD-828 Telmisartan Non-Responder Trial
Not yet reported Chong Kun Dang Pharmaceutical 183 participants Est. completion 2012-08 18 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT01432106
The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome
Not yet reported University of Michigan Est. completion 2012-12 1 siteMetabolic syndrome Other conditions: HypertensionView official trial listing → -
Completed NCT NCT01444885
Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 50 participants Est. completion 2012-07 10 sites Stand-aloneOther conditions: Variant AnginaView official trial listing → -
Status unknown NCT NCT01490255
Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2014-06 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01494727
Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg
Not yet reported HK inno.N Corporation 48 participants Est. completion 2012-04 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01499511
Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study
Imperial College London 1718 participants Est. completion 2016-01-31 1 siteCardiovascular disease Other conditions: Hypertension, DiabetesView official trial listing → -
Status unknown NCT NCT01500590
Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria
Not yet reported Hospital Authority, Hong Kong 1400 participants Est. completion 2019-08 1 siteOther conditions: Diabetes, Hypertensive DiseaseView official trial listing → -
Completed NCT NCT01501253
CKD-828 S-Amlodipine Non-Responder Trial
Not yet reported Chong Kun Dang Pharmaceutical 187 participants Est. completion 2012-09 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01505998
Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions
Not yet reported Dr. Reddy's Laboratories Limited 49 participants Est. completion 2007-05 1 site Stand-aloneOther conditions: FedView official trial listing → -
Completed NCT NCT01506011
Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 50 participants Est. completion 2007-04 1 site Stand-aloneOther conditions: FastingView official trial listing → -
Completed NCT NCT01518855
Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension
Not yet reported Bayer 514 participants Est. completion 2005-04 4 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01518998
A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension
Not yet reported Boryung Pharmaceutical Co., Ltd 420 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT01549496
A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers
Not yet reported Ottawa Hospital Research Institute 1 site Stand-aloneOther conditions: Hepatitis C, HypertensionView official trial listing → -
Completed NCT NCT01556997
Perindopril Amlodipine for the Treatment of Hypertension
Not yet reported Symplmed Pharmaceuticals LLC 837 participants Est. completion 2013-02 48 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT01557153
Vascular Augmentation of Late-life Unremitted Depression (VALUeD)
Not yet reported Gateshead Health NHS Foundation Trust 80 participants Est. completion 2014-04 1 site Stand-aloneOther conditions: DepressionView official trial listing → -
Status unknown NCT NCT01567774
Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2015-06 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01603940
Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine
Not yet reported Hospital Universitario Pedro Ernesto 30 participants Est. completion 2015-01 1 siteOther conditions: Hypertension, Diabetes MellitusView official trial listing → -
Completed NCT NCT01611077
Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg
Not yet reported Institut für Pharmakologie und Präventive Medizin 88 participants Est. completion 2013-01 11 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01613209
Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine
Not yet reported Institut für Pharmakologie und Präventive Medizin 83 participants Est. completion 2012-10 12 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01614366
DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension
Not yet reported TSH Biopharm Corporation Limited 111 participants Est. completion 2014-05 8 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01625494
Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy
Not yet reported Sanofi 158 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT01631409
Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
City Hospital No 40, Saint Petersburg, Russia Est. completion 2021-09Other conditions: Coronary Heart Disease (CHD)View official trial listing → -
Completed NCT NCT01631864
Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects
Not yet reported Novartis Pharmaceuticals 98 participants Est. completion 2013-07 3 sites Stand-aloneOther conditions: Hypertension, Concurrent ObesityView official trial listing → -
Completed NCT NCT01634295
Efficacy and Safety of CKD-828 to Stage 2 Hypertension
Not yet reported Chong Kun Dang Pharmaceutical 103 participants Est. completion 2013-05 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01648231
Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers
Not yet reported GlaxoSmithKline 23 participants Est. completion 2012-09-25 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01652339
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects
Not yet reported Hanlim Pharm. Co., Ltd. 40 participants Est. completion 2012-12 1 site Stand-aloneOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT01658657
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
Not yet reported University of North Carolina, Chapel Hill 17 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: Hypertension, Plasma Renin ActivityView official trial listing → -
Completed NCT NCT01663233
Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine
Not yet reported Novartis Pharmaceuticals 266 participants Est. completion 2013-05 28 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT01665235
Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis
Not yet reported RenJi Hospital 200 participants Est. completion 2014-08 1 siteOther conditions: Blood Pressure Variability, Intracranial Artery StenosisView official trial listing → -
Completed NCT NCT01692301
Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
Not yet reported Novartis Pharmaceuticals 454 participants Est. completion 2015-04 47 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01713647
Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions
Not yet reported Pharmaceutical Research Unit, Jordan 39 participants Est. completion 2012-12 1 site Stand-aloneOther conditions: FastingView official trial listing → -
Completed NCT NCT01713920
Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
Not yet reported Sang Hyun Ihm, MD PhD 68 participants Est. completion 2014-09 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01735890
Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet
Not yet reported HK inno.N Corporation 48 participants Est. completion 2012-11 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01738945
Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose
Not yet reported Gulhane School of Medicine 32 participants Est. completion 2009-05 1 siteOther conditions: We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.View official trial listing → -
Status unknown NCT NCT01748253
ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)
Not yet reported Acrobat Trial Group 80 participants 1 siteOther conditions: Hypertension and Atrial FibrillationView official trial listing → -
Completed NCT NCT01762501
Azilsartan Circadian and Sleep Pressure
Not yet reported Sogo Rinsho Médéfi Co., Ltd. 957 participants Est. completion 2013-12 92 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01776047
A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers
Not yet reported Dong-A Pharmaceutical Co., Ltd. 51 participants Est. completion 2012-09 Stand-aloneOther conditions: Healthy Male VolunteerView official trial listing → -
Completed NCT NCT01797926
Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions
Not yet reported GlaxoSmithKline 102 participants Est. completion 2013-07-25 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01806311
Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg
Not yet reported HanAll BioPharma Co., Ltd. 36 participants Est. completion 2013-08 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01819220
Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome
Not yet reported Yonsei University 16 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01819779
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)
Not yet reported Hanlim Pharm. Co., Ltd. 53 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT01822639
A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study
Not yet reported GlaxoSmithKline 15 participants Est. completion 2013-05-24 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01823913
Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers
Not yet reported Severance Hospital 50 participants Est. completion 2012-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01828359
The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.
Not yet reported Hanmi Pharmaceutical Company Limited 199 participants Est. completion 2013-01 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01830517
Diurnal Variation in Hypertensive Stroke Patients
Not yet reported Hanmi Pharmaceutical Company Limited 84 participants Est. completion 2012-02 1 site Stand-aloneCardiovascular disease Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01835418
Bedtime Administration of Amlodipine Versus Lisinopril
Not yet reported Allina Health System 100 participants Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01838850
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
Not yet reported Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company 344 participants Est. completion 2014-08 39 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01841593
A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers
Not yet reported St Stephens Aids Trust 19 participants Est. completion 2013-09 1 site Stand-aloneOther conditions: HIVView official trial listing → -
Completed NCT NCT01842230
Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Essential Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01842256
Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Essential Hypertension, HyperlipidemiaView official trial listing → -
Status unknown NCT NCT01844570
Levamlodipine Maleate or Amlodipine Besylate for Treatment of Hypertension: A Comparative Effectiveness Research
Peking University First Hospital 10000 participants Est. completion 2015-12 1 siteOther conditions: Primary HypertensionView official trial listing → -
Status unknown NCT NCT01845272
Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate
Not yet reported HK inno.N Corporation 40 participants Est. completion 2013-08 Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT01848873
Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
Not yet reported, Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 756 participants Est. completion 2013-08 16 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Withdrawn NCT NCT01865188
Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension
Not yet reported Novartis Pharmaceuticals Est. completion 2015-04 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01870739
A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension
Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2015-06 4 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01896661
Effect of Antihypertensive Agents Over Sleep Apnea
Not yet reported Hospital de Clinicas de Porto Alegre 53 participants Est. completion 2016-02 1 siteObstructive sleep apnea Other conditions: HypertensionView official trial listing → -
Completed NCT NCT01911780
Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
Not yet reported Boehringer Ingelheim 132 participants Est. completion 2015-01 17 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT01922141
Aliskiren Study of Safety and Efficacy in Senior Hypertensives
Not yet reported Novartis Pharmaceuticals Est. completion 2018-06 Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01922687
Amlodipine Plus/Minus Atorvastatin for Protection of Arteries
Not yet reported Shanghai Institute of Hypertension 109 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Arterial and Arteriolar DisordersView official trial listing → -
Completed NCT NCT01926652
Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 34 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT01956786
Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
Not yet reported, Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 540 participants Est. completion 2014-02 3 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT01964079
Comparision of Blood Pressure Variability Between Amlodipine and Losartan
Not yet reported Wonju Severance Christian Hospital 144 participants Est. completion 2017-05 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01975246
Add-on to Micamlo BP Trial
Not yet reported Boehringer Ingelheim 309 participants Est. completion 2014-07 30 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01977794
Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension
Not yet reported Merck KGaA, Darmstadt, Germany 200 participants Est. completion 2015-03 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT01983735
Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
Not yet reported Chong Kun Dang Pharmaceutical 200 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01984164
CAndesartan vs LIsinopril Effects on the BRain
Not yet reported Emory University 176 participants Est. completion 2018-12-03 1 siteOther conditions: Hypertension, Mild Cognitive ImpairmentView official trial listing → -
Terminated NCT NCT01994408
Default BP Medication Intensification
Not yet reported, Not yet reported Cedars-Sinai Medical Center 3 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01996085
Non-invasive Haemodynamic Assessment in Hypertension
Not yet reported Military Institute od Medicine National Research Institute 144 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: Arterial HypertensionView official trial listing → -
Completed NCT NCT01996449
The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Not yet reported University of Texas Southwestern Medical Center 14 participants Est. completion 2021-04 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02034435
Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism
Not yet reported Vanderbilt University Medical Center 44 participants Est. completion 2019-12 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT02046395
Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus
Not yet reported Tulane University School of Medicine 28 participants Est. completion 2019-12 1 siteType 2 diabetes Other conditions: HypertensionView official trial listing → -
Completed NCT NCT02047175
CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)
Not yet reported Chong Kun Dang Pharmaceutical 64 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02058446
PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension
Not yet reported TSH Biopharm Corporation Limited 36 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT02058472
Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
Not yet reported Dong-A Pharmaceutical Co., Ltd. 30 participants Est. completion 2014-05 Stand-aloneOther conditions: Healthy Adult VolunteersView official trial listing → -
Terminated NCT NCT02058823
Intermittent Hypoxia 2: Cardiovascular and Metabolism
Not yet reported University Hospital, Grenoble 12 participants Est. completion 2017-03-16 1 siteObstructive sleep apnea Other conditions: Hypoxia, Sleep ApneaView official trial listing → -
Status unknown NCT NCT02059616
A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
Not yet reported HK inno.N Corporation 384 participants Est. completion 2015-12 20 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02060019
Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects
Not yet reported HK inno.N Corporation 57 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02062645
Study of Efficacy and Safety of CVAA489 in Hypertensive Patients
Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2015-09 8 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02064556
CKD-330 Drug-Drug Interaction Study (Amlodipine)
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02064621
CKD-330 Drug-Drug Interaction Study (Candesartan)
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02065492
Amlodipine for Myocardial Iron in Thalassemia
Not yet reported, Not yet reported Aga Khan University 20 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: ThalassemiaView official trial listing → -
Completed NCT NCT02068495
Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"
Takeda 3409 participants Est. completion 2013-05-31Other conditions: HypertensionView official trial listing → -
Completed NCT NCT02069821
Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects
Not yet reported HK inno.N Corporation 56 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02072330
Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.
Not yet reported, Not yet reported Takeda 353 participants Est. completion 2013-12 13 sitesOther conditions: Grade I or II Essential HypertensionView official trial listing → -
Completed NCT NCT02075619
Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
Not yet reported GlaxoSmithKline 24 participants Est. completion 2014-07-11 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02089399
Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 32 participants Est. completion 2014-06 1 siteOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT02099123
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
Not yet reported Monash University 9971 participants Est. completion 2025-12 6 sitesOther conditions: Independent Living, Disability Free Survival, Elderly, HealthyView official trial listing → -
Completed NCT NCT02121041
Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study
Not yet reported Anthony J Viera, MD, MPH 28 participants Est. completion 2016-07 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02121535
Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use
Not yet reported Boehringer Ingelheim 72 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02128386
Medication Adherence and "True" Resistance in Patients With Resistant Hypertension
Charite University, Berlin, Germany 50 participants Est. completion 2016-03 1 siteOther conditions: Hypertensive Disease, Hypertension, Resistant to Conventional TherapyView official trial listing → -
Completed NCT NCT02129192
Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use
Not yet reported Boehringer Ingelheim 72 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02130687
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
Not yet reported Vanderbilt University 106 participants Est. completion 2020-08 1 siteType 2 diabetes Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02140489
Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin
Not yet reported Hanmi Pharmaceutical Company Limited 30 participants Est. completion 2014-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02148991
Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction
Elpen Pharmaceutical Co. Inc. 100 participants Est. completion 2017-01 2 sitesOther conditions: Hypertension, Cardiac Arrhythmias, Diabetes Mellitus, Renal Insufficiency, Sleep ApneaView official trial listing → -
Completed NCT NCT02152306
Fimasartan/Amlodipine Combination Phase III
Not yet reported Boryung Pharmaceutical Co., Ltd 143 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02152969
Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)
Not yet reported Yuhan Corporation 66 participants Est. completion 2014-11 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02166398
A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers
Not yet reported Korea United Pharm. Inc. 46 participants Est. completion 2014-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02172040
Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy
Not yet reported Kitov Pharmaceuticals, Ltd. 152 participants Est. completion 2015-11-19 10 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02173912
Bioequivalence Study of CJ-30059
Not yet reported HK inno.N Corporation 32 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02177409
Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension
Not yet reported Boehringer Ingelheim 431 participantsOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02181816
Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"
Takeda 1090 participants Est. completion 2017-01-31 2 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02183675
Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers
Not yet reported Boehringer Ingelheim 36 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02186496
Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02193308
Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers
Not yet reported Boehringer Ingelheim 84 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02194309
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers
Not yet reported Boehringer Ingelheim 24 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02205151
To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets
Not yet reported Boryung Pharmaceutical Co., Ltd 86 participants Est. completion 2014-09 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02206165
A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
Not yet reported Chong Kun Dang Pharmaceutical 456 participants Est. completion 2015-06 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT02213224
Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
Not yet reported Nanfang Hospital, Southern Medical University 180 participants Est. completion 2017-09 1 siteMASLDView official trial listing → -
Completed NCT NCT02231788
The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy
Not yet reported Chong Kun Dang Pharmaceutical 217 participants Est. completion 2018-03 11 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT02232880
Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
Not yet reported Vanderbilt University Medical Center 1 participants Est. completion 2015-06 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02233218
The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
Not yet reported Yuhan Corporation 60 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Healthy Male VolunteerView official trial listing → -
Completed NCT NCT02250833
CKD-828 (80/5mg) Pharmacokinetic Study
Not yet reported Chong Kun Dang Pharmaceutical 69 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02259777
Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers
Not yet reported Boehringer Ingelheim 40 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02259790
Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers
Not yet reported Boehringer Ingelheim 30 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02259803
Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers
Not yet reported Boehringer Ingelheim 30 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02259816
Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers
Not yet reported Boehringer Ingelheim 38 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02259829
Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers
Not yet reported Boehringer Ingelheim 84 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02261064
Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers
Not yet reported Boehringer Ingelheim 32 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02277691
A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension
Not yet reported Takeda 341 participants Est. completion 2016-04-25 38 sitesOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02278471
The SCCS Polypill Pilot Trial
Not yet reported Vanderbilt University 303 participants Est. completion 2018-06-27 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02292069
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition
Not yet reported Dr. Reddy's Laboratories Limited 90 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02294539
Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients
Not yet reported Chong-Jin Kim 231 participants Est. completion 2016-05-18 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02295046
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition
Not yet reported Dr. Reddy's Laboratories Limited 80 participants Est. completion 2011-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02312375
Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients
Not yet reported Seoul National University Hospital 46 participants Est. completion 2017-03 1 site Stand-aloneOther conditions: Diabetes Mellitus, HypertensionView official trial listing → -
Completed NCT NCT02353806
Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation
Not yet reported University of Texas Southwestern Medical Center 16 participants Est. completion 2016-09 1 site Stand-aloneOther conditions: Chronic Hypertension in PregnancyView official trial listing → -
Completed NCT NCT02358824
CKD-828 (80/5mg) Pharmacokinetic Study
Not yet reported Chong Kun Dang Pharmaceutical 48 participants Est. completion 2015-06 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02364089
Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
Not yet reported University Hospital, Bordeaux 78 participants Est. completion 2022-11-23 17 sitesOther conditions: Adrenal IncidentalomasView official trial listing → -
Completed NCT NCT02368652
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy
Not yet reported HK inno.N Corporation 181 participants Est. completion 2015-11 19 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02368665
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
Not yet reported HK inno.N Corporation 180 participants Est. completion 2016-11 19 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02373163
INTERVENCION Trial
Not yet reported Prevencion 166 participants Est. completion 2016-06-01 1 siteOther conditions: Blood Pressure, HighView official trial listing → -
Completed NCT NCT02377661
Lowering Blood Pressure in Primary Care in Vienna
Not yet reported Wilhelminenspital Vienna 229 participants Est. completion 2017-05-30 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02378064
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
Not yet reported CHEOL WHAN LEE, M.D., Ph.D 50 participants Est. completion 2017-12 1 siteOther conditions: Inflammation Plaque, Atherosclerotic, Coronary Disease, Renin-Angiotensin SystemView official trial listing → -
Completed NCT NCT02387554
Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405
Not yet reported Hanmi Pharmaceutical Company Limited 33 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: Hypertension(HTN)View official trial listing → -
Completed NCT NCT02387619
The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine
Not yet reported Jeil Pharmaceutical Co., Ltd. 41 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02397538
Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects
Not yet reported Boryung Pharmaceutical Co., Ltd 50 participants Est. completion 2015-04 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02408172
Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome
Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 20 participants Est. completion 2017-12 2 sites Stand-aloneOther conditions: Sleep Apnea Syndrome, HypertensionView official trial listing → -
Completed NCT NCT02412761
Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
Not yet reported The University of Texas Health Science Center, Houston 42 participants Est. completion 2016-07 1 siteOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT02415192
Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients
LG Life Sciences 2001 participants Est. completion 2016-11 1 siteOther conditions: Lower Leg Edema, Orthostatic HypertensionView official trial listing → -
Completed NCT NCT02433119
The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy
Not yet reported Dong-A ST Co., Ltd. 238 participants Est. completion 2016-09-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02449811
RAS Peptide Profiles in Patients With Arterial Hypertension
Insel Gruppe AG, University Hospital Bern 107 participants Est. completion 2018-11 1 siteOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT02474420
Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients
Not yet reported Kevin H.M. Kuo, MD, MSc, FRCPC 60 participants Est. completion 2018-06 1 site Stand-aloneOther conditions: Beta-Thalassemia, Iron OverloadView official trial listing → -
Completed NCT NCT02496910
PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton
Not yet reported Yuhan Corporation 180 participants Est. completion 2015-09 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02504606
Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject
Not yet reported Huons Co., Ltd. 60 participants Est. completion 2014-10 Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02513927
The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese
Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 40 participants Est. completion 2018-10 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02519010
A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)
Not yet reported Genuine Research Center, Egypt 36 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02526875
Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
Not yet reported Chong Kun Dang Pharmaceutical 208 participants Est. completion 2017-11 10 sitesOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT02539810
Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)
Not yet reported Assistance Publique - Hôpitaux de Paris 4 participants Est. completion 2017-07 15 sites Stand-aloneOther conditions: Hypertension, Hypertension Resistant to Conventional Therapy, Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 PercentView official trial listing → -
Completed NCT NCT02544776
Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients
Not yet reported Ahmed Fathy Ali Mohamed Ghanem 60 participants Est. completion 2015-09 Stand-aloneOther conditions: Female Infertility Associated With AnovulationView official trial listing → -
Completed NCT NCT02548286
Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs
Not yet reported Chong Kun Dang Pharmaceutical 53 participants Est. completion 2015-09 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02563405
The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients
Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 30 participants Est. completion 2018-10 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02569814
A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
Not yet reported Boryung Pharmaceutical Co., Ltd 100 participants Est. completion 2015-12 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02586311
CKD-330 Phase 3 Trial in Amlodipine Non-responder
Not yet reported Chong Kun Dang Pharmaceutical 160 participants Est. completion 2016-09 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT02608242
PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin
Not yet reported Yuhan Corporation 123 participants Est. completion 2016-06 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02620163
Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment
Not yet reported Yuhan Corporation 381 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02644395
Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus
Not yet reported Erasmus Medical Center 49 participants Est. completion 2016-12-19 1 siteOther conditions: Hypertension, Kidney TransplantationView official trial listing → -
Completed NCT NCT02651870
Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Not yet reported Chong Kun Dang Pharmaceutical 135 participants Est. completion 2016-02-29 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02655029
Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination
Servier Hellas Pharmaceuticals Ltd. 2285 participants Est. completion 2016-12-21 1 siteOther conditions: Adherence to Medication Regime, Hypertensive DiseaseView official trial listing → -
Status unknown NCT NCT02665832
Study of DWJ1351 in Healthy Male Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 58 participants Est. completion 2016-06 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02671695
Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia
Not yet reported Tanta University 40 participants Est. completion 2018-04 1 site Stand-aloneOther conditions: Beta Thalassemia MajorView official trial listing → -
Completed NCT NCT02699645
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
Not yet reported The George Institute 1671 participants Est. completion 2025-08-27 58 sites Stand-aloneOther conditions: Intracerebral Haemorrhage (ICH), HypertensionView official trial listing → -
Completed NCT NCT02707913
Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations
Not yet reported Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited 17 participants Est. completion 2016-09 Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02710539
Once-daily Fixed Combination of Three Antihypertensive Drugs
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2020-03 1 siteOther conditions: Arterial HypertensionView official trial listing → -
Status unknown NCT NCT02710552
Low-dose Combination of Three Antihypertensive Drugs
Not yet reported University of Roma La Sapienza 100 participants Est. completion 2020-03 1 siteOther conditions: Arterial HypertensionView official trial listing → -
Completed NCT NCT02734355
Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation
Not yet reported Research Institute for Complex Problems of Cardiovascular Diseases, Russia 64 participants Est. completion 2016-02Other conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT02738632
Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients
Not yet reported IlDong Pharmaceutical Co Ltd 300 participants Est. completion 2016-08 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02739672
Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers
Not yet reported IlDong Pharmaceutical Co Ltd 40 participants Est. completion 2016-04-06 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02742467
Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans
Not yet reported University of Abuja 702 participants Est. completion 2018-06-01 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02744456
N-of-1 Trials for Blood Pressure Medications in Adults
Not yet reported Columbia University 10 participants Est. completion 2017-12-31 1 siteOther conditions: Hypertension, High Blood PressureView official trial listing → -
Completed NCT NCT02774460
The Precision Hypertension Care Study
Not yet reported Uppsala University 280 participants Est. completion 2021-06-11 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02789475
DP-R212 Pharmacokinetic Study
Not yet reported Alvogen Korea 38 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiasView official trial listing → -
Completed NCT NCT02801526
Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2015-08 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02811731
Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2015-08 Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02814500
DP-R212 Pharmacokinetic Study Phase I
Not yet reported Alvogen Korea 36 participants Est. completion 2016-09 Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT02817503
Feasibility Study of the Intensive Systolic Blood Pressure Control
Not yet reported Second Affiliated Hospital of Nanchang University 100 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: Hypertension, HyperhomocysteinemiaView official trial listing → -
Completed NCT NCT02834403
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
Not yet reported, Not yet reported The Methodist Hospital Research Institute 37 participants Est. completion 2021-01 1 site Stand-aloneOther conditions: Metastatic Triple Negative Breast CancerView official trial listing → -
Completed NCT NCT02847338
Comparison of Optimal Hypertension Regimens
Not yet reported Cambridge University Hospitals NHS Foundation Trust 940 participants Est. completion 2023-10 14 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT02850081
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
Not yet reported Columbia University 31 participants Est. completion 2020-03-31 7 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery StenosisView official trial listing → -
Completed NCT NCT02893358
Antihypertensive Treatment in Masked Hypertension
Not yet reported Yan Li 320 participants Est. completion 2022-03-30 1 siteOther conditions: Masked HypertensionView official trial listing → -
Completed NCT NCT02896621
Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea
Not yet reported Hospital de Clinicas de Porto Alegre 69 participants Est. completion 2017-02-14 1 siteOther conditions: Hypertension, Sleep ApneaView official trial listing → -
Status unknown NCT NCT02900729
Randomized Controlled Trial of Renal Denervation for Resistant Hypertension
Not yet reported Shanghai WiseGain Medical Devices Co., Ltd. 254 participants Est. completion 2018-02 13 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02913664
Risk Reduction for Alzheimer's Disease
Not yet reported, Not yet reported University of Texas Southwestern Medical Center 513 participants Est. completion 2022-01-31 4 sites Stand-aloneOther conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02916602
A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
Not yet reported Hanmi Pharmaceutical Company Limited 340 participants Est. completion 2016-09 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02920047
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects
Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-01 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02933658
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
Not yet reported Daewon Pharmaceutical Co., Ltd. 71 participants Stand-aloneOther conditions: Hypertension and DyslipidemiaView official trial listing → -
Terminated NCT NCT02940548
Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness
Not yet reported Jing Liu 99 participants Est. completion 2020-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02944734
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 392 participants Est. completion 2015-12 23 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT02951962
A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin
Not yet reported Yuhan Corporation 60 participants Est. completion 2016-09 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02962258
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2011-06 Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT02962336
Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
Not yet reported Torrent Pharmaceuticals Limited 34 participants Est. completion 2011-06 Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Status unknown NCT NCT02966717
Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
Not yet reported Zhujiang Hospital 116 participants Est. completion 2021-10 1 siteOther conditions: Renal Insufficiency, Chronic, Nephrotic SyndromeView official trial listing → -
Withdrawn NCT NCT02969265
An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension
Not yet reported Takeda Est. completion 2018-07-26 25 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02973035
Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension
Not yet reported Asan Medical Center 104 participants Est. completion 2020-01-06 4 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02974439
Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers
Not yet reported Shanghai Haini Pharmaceutical Co., Ltd. 60 participants Est. completion 2017-03-21 1 site Stand-aloneOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT02979197
Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives
Not yet reported Kitov Pharma Ltd 105 participants Est. completion 2017-07-21 9 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02988362
Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
Not yet reported HanAll BioPharma Co., Ltd. 42 participants Est. completion 2017-02-04 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT02995720
A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2017-05-30 Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02995954
Fixed vs Free Dose of ACEi/CCB Combination Therapy
Not yet reported Guido Iaccarino 100 participants Est. completion 2015-12 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT02996916
Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue
Not yet reported Kurume University 100 participants Est. completion 2020-12 1 siteOther conditions: Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential HypertensionView official trial listing → -
Completed NCT NCT03009474
Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers
Not yet reported HK inno.N Corporation 52 participants Est. completion 2015-04 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiasView official trial listing → -
Completed NCT NCT03009487
A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
Not yet reported Daewoong Pharmaceutical Co. LTD. 265 participants Est. completion 2018-04 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiasView official trial listing → -
Status unknown NCT NCT03015311
Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 8000 participants Est. completion 2021-12-31 42 sites Stand-aloneOther conditions: Primary HypertensionView official trial listing → -
Completed NCT NCT03021265
To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension
Boehringer Ingelheim 676 participants Est. completion 2019-04-11 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03024476
Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance
Not yet reported Seoul National University Bundang Hospital 67 participants Est. completion 2017-12-07 3 sites Stand-aloneCardiovascular disease Other conditions: HypertensionView official trial listing → -
Completed NCT NCT03032315
Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers
Not yet reported IlDong Pharmaceutical Co Ltd 44 participants Est. completion 2016-12-27 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03038451
Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients
Not yet reported Neutec Ar-Ge San ve Tic A.Ş 43 participants Est. completion 2017-02-14 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT03047538
Fixed Combination for Lipid and Blood Pressure Control
Not yet reported Charles University, Czech Republic Est. completion 2019-12-31 1 siteOther conditions: Arterial Hypertension, Dyslipidemias, Blood Pressure, Lipid Metabolism DisordersView official trial listing → -
Status unknown NCT NCT03054467
Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina
Not yet reported Kosin University Gospel Hospital 150 participants Est. completion 2019-04-28Other conditions: Quality of LifeView official trial listing → -
Completed NCT NCT03067688
Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
Not yet reported Yuhan Corporation 202 participants Est. completion 2018-03-27 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Terminated NCT NCT03082014
Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function
Not yet reported Ludwig-Maximilians - University of Munich 101 participants Est. completion 2022-07-28 5 sitesOther conditions: Cerebral Small Vessel DiseasesView official trial listing → -
Completed NCT NCT03088254
Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin
Not yet reported Jeil Pharmaceutical Co., Ltd. 126 participants Est. completion 2017-12-04 12 sites Stand-aloneOther conditions: Dyslipidemia With HypertensionView official trial listing → -
Terminated NCT NCT03106597
Manidipine Versus Amlodipine in Patients With Hypertension
Not yet reported Korea University Guro Hospital 46 participants Est. completion 2019-08-14 3 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03116516
Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin
Not yet reported Yuhan Corporation 62 participants Est. completion 2017-05-26 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Status unknown NCT NCT03147092
Matão Controlling Hypertension (MatCH Study): Rationale and Design
Not yet reported Centro Neurológico de Pesquisa e Reabiitação, Brazil 15000 participants Est. completion 2021-06-30 Stand-aloneOther conditions: Hypertension, Blood PressureView official trial listing → -
Completed NCT NCT03156842
Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
Not yet reported Boryung Pharmaceutical Co., Ltd 138 participants Est. completion 2018-12-07 1 site Stand-aloneOther conditions: Essential Hypertension, DyslipidemiaView official trial listing → -
Status unknown NCT NCT03195023
Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
Not yet reported Hospital General Universitario Gregorio Marañon 106 participants Est. completion 2022-12 1 siteOther conditions: Renal Insufficiency, Chronic, ProteinuriaView official trial listing → -
Withdrawn NCT NCT03205137
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
Boehringer Ingelheim Est. completion 2022-07-11 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03210532
Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia
Not yet reported Daewon Pharmaceutical Co., Ltd. 129 participants Est. completion 2017-09 1 site Stand-aloneOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT03226275
Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants
Not yet reported Merck KGaA, Darmstadt, Germany 32 participants Est. completion 2017-09-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT03226340
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
Not yet reported Seoul National University Bundang Hospital 170 participants Est. completion 2018-03-31 10 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT03231982
Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
Not yet reported HK inno.N Corporation 210 participants Est. completion 2019-05-31 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03247140
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 40 participants Est. completion 2017-11-27 1 site Stand-aloneOther conditions: Hypertension With DyslipidemiaView official trial listing → -
Completed NCT NCT03255551
Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure
Seoul National University Bundang Hospital 50 participants Est. completion 2015-12-31Other conditions: HypertensionView official trial listing → -
Completed NCT NCT03276598
A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension
Not yet reported Helsinki University Central Hospital 233 participants Est. completion 2004-04-01 1 siteOther conditions: Hypertension, PharmacogeneticsView official trial listing → -
Status unknown NCT NCT03294070
Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension
Not yet reported Centro Universitario de Ciencias de la Salud, Mexico 53 participants Est. completion 2018-08 Stand-aloneOther conditions: Arterial HypertensionView official trial listing → -
Withdrawn NCT NCT03319823
Treating Nocturnal Hypertension and Nocturia in African American Men
Not yet reported Cedars-Sinai Medical Center Est. completion 2021-02-01 1 site Stand-aloneOther conditions: High Blood PressureView official trial listing → -
Completed NCT NCT03354143
Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)
Not yet reported University of Texas Southwestern Medical Center 85 participants Est. completion 2024-03-30 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03371797
Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial
PharmEvo Pvt Ltd 800 participants Est. completion 2018-11-05 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT03390465
Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects
Not yet reported Boryung Pharmaceutical Co., Ltd 36 participants Est. completion 2018-01-30 1 siteOther conditions: Drug-Drug InteractionView official trial listing → -
Completed NCT NCT03461003
N-of-1 Trials In Children With Hypertension
Not yet reported The University of Texas Health Science Center, Houston 49 participants Est. completion 2021-05-02 1 site Stand-aloneOther conditions: Pediatric HypertensionView official trial listing → -
Completed NCT NCT03461081
Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 32 participants Est. completion 2017-12-12 1 site Stand-aloneOther conditions: Hypertension With HyperlipidemiaView official trial listing → -
Completed NCT NCT03474562
High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
Not yet reported Yuhan Corporation 100 participants Est. completion 2019-06-07 4 sitesCardiovascular diseasePrediabetes Other conditions: HypertensionView official trial listing → -
Completed NCT NCT03476616
Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients
Not yet reported Hippocration General Hospital 198 participants Est. completion 2025-06-30 1 siteOther conditions: Hypertension, ObesityView official trial listing → -
Status unknown NCT NCT03489317
Gut Microbiomes in Patients With Metabolic Syndrome
Chinese University of Hong Kong 1000 participants Est. completion 2021-12 2 sitesMetabolic syndromeView official trial listing → -
Completed NCT NCT03504735
Caduet and TLC Intervention in Metabolic Syndrome
Not yet reported The University of Texas Medical Branch, Galveston 53 participants Est. completion 2016-02-28Metabolic syndromeView official trial listing → -
Completed NCT NCT03515772
Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients
Centre Hospitalier Universitaire Vaudois 21 participants Est. completion 2019-08-29 2 sitesCardiovascular disease Other conditions: HIV Infections, Drug InteractionsView official trial listing → -
Completed NCT NCT03536598
Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia
Not yet reported HK inno.N Corporation 203 participants Est. completion 2017-09-04 Stand-aloneOther conditions: Hypertension With HyperlipidemiaView official trial listing → -
Completed NCT NCT03553810
Role of ARNi in Ventricular Remodeling in Hypertensive LVH
Not yet reported National Heart Centre Singapore 80 participants Est. completion 2024-06-28 1 site Stand-aloneOther conditions: Hypertensive Heart DiseaseView official trial listing → -
Completed NCT NCT03566316
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia
Not yet reported IlDong Pharmaceutical Co Ltd 134 participants Est. completion 2017-06-16 1 site Stand-aloneOther conditions: Hypertension With HyperlipidemiaView official trial listing → -
Status unknown NCT NCT03578042
Fixed-Free HTN Trial
Not yet reported Hotel Dieu de France Hospital 100 participants Est. completion 2019-12-30 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT03626259
Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension
Not yet reported Centro Universitario de Ciencias de la Salud, Mexico 28 participants Est. completion 2019-06-14 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT03626506
Spironolactone Versus Indapamide in Obese and Hypertensive Patients
Not yet reported Peking University Third Hospital 400 participants Est. completion 2020-12 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03629067
Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects
Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2018-12-27 1 site Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT03635125
Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine
Not yet reported Trinity Hypertension & Metabolic Research Institute 40 participants Est. completion 2011-07-18 1 siteOther conditions: JNC 7 Stage 1 or 2 HypertensionView official trial listing → -
Status unknown NCT NCT03639480
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
Not yet reported HK inno.N Corporation 180 participants Est. completion 2018-10 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03639493
Bioequivalence Study of CJ-30060 in Healthy Male Volunteers
Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-05-17 1 site Stand-aloneOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT03640312
Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension
Not yet reported Washington University School of Medicine 62 participants Est. completion 2024-07-31 2 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03648333
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)
Not yet reported Hanlim Pharm. Co., Ltd. 27 participants Est. completion 2014-06 Stand-aloneOther conditions: Healthy Male SubjectsView official trial listing → -
Status unknown NCT NCT03653845
Adrenal Artery Ablation for Primary Aldosteronism
Not yet reported Third Military Medical University 40 participants Est. completion 2020-01-01 2 sites Stand-aloneOther conditions: Primary Aldosteronism, HypertensionView official trial listing → -
Completed NCT NCT03657472
Bioequivalence Study of CJ-30061 in Healthy Male Volunteers
Not yet reported HK inno.N Corporation 42 participants Est. completion 2016-11-09 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03657550
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
Not yet reported Conjupro Biotherapeutics, Inc. 36 participants Est. completion 2018-09-06 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT03660397
Adrenal Artery Ablation for Uncontrolled Hypertension
Not yet reported Third Military Medical University 40 participants Est. completion 2020-01-01 1 site Stand-aloneOther conditions: Uncontrolled HypertensionView official trial listing → -
Completed NCT NCT03662620
Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
Not yet reported Yuhan Corporation 67 participants Est. completion 2018-12-22 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03666351
Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
Not yet reported Hanmi Pharmaceutical Company Limited 128 participants Est. completion 2022-07-25 1 site Stand-aloneOther conditions: Aortic Stenosis, Aortic Regurgitation, Hypertension, LVM, Left Ventricular HypertrophyView official trial listing → -
Status unknown NCT NCT03667677
Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety
Not yet reported Chongqing Medical University 256 participants Est. completion 2020-07-01 7 sites Stand-aloneOther conditions: Hypertension, AnxietyView official trial listing → -
Completed NCT NCT03682692
ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)
Not yet reported Shanghai Jiao Tong University School of Medicine 560 participants Est. completion 2022-03-31 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03683069
Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN
Not yet reported Brigham and Women's Hospital 90 participants Est. completion 2024-01-31 1 site Stand-aloneOther conditions: Hypertension, Genetics HypertensionView official trial listing → -
Completed NCT NCT03707899
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers
Not yet reported Jeil Pharmaceutical Co., Ltd. 49 participants Est. completion 2019-05-22 1 site Stand-aloneOther conditions: Hypertension With DyslipidemiaView official trial listing → -
Withdrawn NCT NCT03722381
Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis
University of Michigan Est. completion 2020-01-30 1 siteOther conditions: Hemodialysis, PharmacokineticsView official trial listing → -
Completed NCT NCT03722524
The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension
Servier Russia 1247 participants Est. completion 2019-07-17 51 sitesOther conditions: Arterial HypertensionView official trial listing → -
Completed NCT NCT03738761
Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine
Not yet reported KRKA 471 participants Est. completion 2019-09-27 34 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03747978
Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes
Not yet reported Yaounde Central Hospital 30 participants Est. completion 2017-05-30 1 site Stand-aloneType 2 diabetes Other conditions: HypertensionView official trial listing → -
Completed NCT NCT03753477
Clinical Trial to Investigate the Efficacy and Safety of DWJ1351
Not yet reported Daewoong Pharmaceutical Co. LTD. 64 participants Est. completion 2018-02-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT03757390
Bioequivalence Study of CJ-30060 in Healthy Volunteers
Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-12-14 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Terminated NCT NCT03783754
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study
Not yet reported The George Institute 4 participants Est. completion 2021-03-21 3 sites Stand-aloneCardiovascular disease Other conditions: Cerebral Small Vessel Diseases, Intracerebral Hemorrhage, Vascular Dementia, HypertensionView official trial listing → -
Terminated NCT NCT03785067
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
Not yet reported The George Institute 1 participants Est. completion 2021-02-03 4 sites Stand-aloneCardiovascular disease Other conditions: Cognitive Decline, Intracerebral Hemorrhage, Dementia, Vascular, Cerebral Small Vessel Diseases, HypertensionView official trial listing → -
Completed NCT NCT03847506
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
Not yet reported HK inno.N Corporation 127 participants Est. completion 2020-12-02 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT03860220
The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
Not yet reported Hyo-Soo Kim 252 participants Est. completion 2023-09-07 9 sitesOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT03889145
A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide
Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2014-02-19 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03897868
A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
Not yet reported Hanmi Pharmaceutical Company Limited 248 participants Est. completion 2020-02-26 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03912285
The Pharmacokinetic Interaction Between Amlodipine and Losartan
Not yet reported Korea University Anam Hospital 24 participants Est. completion 2009-06-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT03938389
The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
Not yet reported Ohio State University 90 participants Est. completion 2026-06 1 sitePrediabetes Other conditions: Obesity, Blood PressureView official trial listing → -
Completed NCT NCT03946514
Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
Not yet reported Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2024-08-31 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03951207
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
Not yet reported Yuhan Corporation 259 participants Est. completion 2021-09-29 1 site Stand-aloneOther conditions: Dyslipidemias, HypertensionView official trial listing → -
Status unknown NCT NCT03956823
Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2021-12-01 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03967496
Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors
Sultan Qaboos University 402 participants Est. completion 2019-03-31 1 siteOther conditions: Delirium, Anesthesia; Adverse EffectView official trial listing → -
Withdrawn NCT NCT03978884
Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes
Not yet reported The University of The West Indies Est. completion 2020-12-31 1 site Stand-aloneOther conditions: Diabetes Mellitus, HypertensionView official trial listing → -
Completed NCT NCT03990480
Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level
Not yet reported Damanhour University 230 participants Est. completion 2019-04-10 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT03991442
BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
Not yet reported Boryung Pharmaceutical Co., Ltd 257 participants Est. completion 2021-03-02 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT04036409
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients
Not yet reported Hospital Israelita Albert Einstein 4368 participants Est. completion 2026-07-08 30 sites Stand-aloneCardiovascular disease Other conditions: Blood Pressure, Cognitive Impairment, Vascular DiseasesView official trial listing → -
Completed NCT NCT04040634
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)
Not yet reported Hospital Israelita Albert Einstein 9476 participants Est. completion 2026-07-08 32 sites Stand-aloneCardiovascular disease Other conditions: Diabetes Mellitus, High Blood Pressure, Cognitive ImpairmentView official trial listing → -
Completed NCT NCT04074551
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Not yet reported Hanmi Pharmaceutical Company Limited 145 participants Est. completion 2020-03-17 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT04081844
A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.
Not yet reported Hanmi Pharmaceutical Company Limited 31 participants Est. completion 2018-06-28 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04085562
Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.
Not yet reported Alexandria University 46 participants Est. completion 2021-02-01 1 site Stand-aloneOther conditions: Hypertension, RenalView official trial listing → -
Status unknown NCT NCT04085627
A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland)
Not yet reported Second Affiliated Hospital of Wenzhou Medical University 84 participants Est. completion 2019-12-26 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT04111419
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Not yet reported Shanghai Jiao Tong University School of Medicine 1200 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Atrial Fibrillation, HypertensionView official trial listing → -
Completed NCT NCT04120753
Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab
Not yet reported Daewoong Pharmaceutical Co. LTD. 106 participants Est. completion 2021-07-06 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Withdrawn NCT NCT04121299
Mechanism of Masked Hypertension - Intervention
Not yet reported University of Alabama at Birmingham Est. completion 2026-06 1 siteOther conditions: Masked HypertensionView official trial listing → -
Completed NCT NCT04158076
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
Not yet reported Addpharma Inc. 131 participants Est. completion 2021-01-14 1 site Stand-aloneOther conditions: Hypercholesterolemia, HypertensionView official trial listing → -
Completed NCT NCT04158154
Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design
Not yet reported Washington University School of Medicine 21922 participants Est. completion 2023-12-31 60 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT04161001
Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
Not yet reported Daewoong Pharmaceutical Co. LTD. 237 participants Est. completion 2022-02-02 1 site Stand-aloneOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT04179019
Calcium Channel Blockade in Primary Aldosteronism
Not yet reported Brigham and Women's Hospital 15 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)View official trial listing → -
Status unknown NCT NCT04185090
To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults
Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2020-04 Stand-aloneOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT04218552
Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
Not yet reported Addpharma Inc. 176 participants Est. completion 2021-02-25 1 siteOther conditions: Hypertension,EssentialView official trial listing → -
Completed NCT NCT04245046
Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-02-18 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04262765
Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin
Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-03-26 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT04306627
Effect of Atorvastatin on Carotid Intima Media Thickness
Not yet reported Yerevan State Medical University 200 participants Est. completion 2021-02-28Other conditions: Essential Hypertension, HypercholesterolemiaView official trial listing → -
Completed NCT NCT04322266
A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
Not yet reported Hanmi Pharmaceutical Company Limited 61 participants Est. completion 2019-02-13 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT04329806
Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity
Not yet reported Italo Biaggioni 10 participants Est. completion 2022-07-27 1 siteOther conditions: Obesity-Associated Insulin ResistanceView official trial listing → -
Suspended NCT NCT04330300
Coronavirus (COVID-19) ACEi/ARB Investigation
Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 siteOther conditions: Hypertension, COVID-19View official trial listing → -
Completed NCT NCT04364139
African American Study of Kidney Disease and Hypertension
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1094 participants Est. completion 2007-06-30 Stand-aloneOther conditions: Hypertensive Nephrosclerosis, Chronic Renal InsufficiencyView official trial listing → -
Completed NCT NCT04411875
Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects
Not yet reported The Affiliated Hospital of Qingdao University 48 participants Est. completion 2019-02-15 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT04434664
BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF
Not yet reported University of Pennsylvania 50 participants Est. completion 2024-12-20 1 siteHeart failure Other conditions: HypertensionView official trial listing → -
Status unknown NCT NCT04455178
The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure
Not yet reported Shanghai Jiao Tong University School of Medicine 200 participants Est. completion 2023-12-31 4 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT04467931
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
University of Utah 22213 participants Est. completion 2020-12-31 1 siteOther conditions: Hypertension, COVIDView official trial listing → -
Status unknown NCT NCT04474899
Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension
Not yet reported Royal Perth Hospital 120 participants Est. completion 2024-06-24 1 site Stand-aloneOther conditions: Obesity, HypertensionView official trial listing → -
Completed NCT NCT04488978
Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
Not yet reported Handok Inc. 440 participants Est. completion 2021-11-09 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT04518293
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Not yet reported George Medicines PTY Limited 1385 participants Est. completion 2023-09-01 89 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT04518306
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Not yet reported George Medicines PTY Limited 755 participants Est. completion 2023-10-18 47 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT04521023
A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Not yet reported Chong Kun Dang Pharmaceutical 132 participants Est. completion 2020-06-03 14 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT04521582
Management of Hypertension Utilizing Trained Community Health Worker in Rural Municipalities of Nepal
Not yet reported Johns Hopkins Bloomberg School of Public Health 1428 participants Est. completion 2022-07-20 2 sites Stand-aloneOther conditions: Hypertension,EssentialView official trial listing → -
Status unknown NCT NCT04554303
Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension
Ahn-Gook Pharmaceuticals Co.,Ltd 80 participants Est. completion 2022-05-23 1 siteOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT04559074
Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension
Not yet reported Queen Mary University of London 343 participants Est. completion 2021-11-19 2 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT04667624
Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers
Not yet reported Hanlim Pharm. Co., Ltd. 32 participants Est. completion 2020-05-18 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT04686643
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension
Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 306 participants Est. completion 2022-05-01 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT04692467
Treatment of Early Hypertension Among Persons Living With HIV in Haiti
Not yet reported Weill Medical College of Cornell University 250 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: HIV/AIDS, Pre HypertensionView official trial listing → -
Completed NCT NCT04740840
Anti Inflammatory Treatment of Hypertension
Not yet reported, Not yet reported Affiliated Hospital of North Sichuan Medical College 200 participants Est. completion 2015-05-02Other conditions: HypertensionView official trial listing → -
Completed NCT NCT04790279
Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
Not yet reported Prisma Health-Upstate 175 participants Est. completion 2023-01-25 1 site Stand-aloneOther conditions: Hypertension in PregnancyView official trial listing → -
Completed NCT NCT04840342
MR Antagonist and LSD1
Not yet reported Brigham and Women's Hospital 300 participants Est. completion 2025-12-15 1 site Stand-aloneOther conditions: Hypertension, Mineralocorticoid ExcessView official trial listing → -
Status unknown NCT NCT04929600
Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
Not yet reported Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2023-12 1 site Stand-aloneOther conditions: Hypertension, Left Ventricular HypertrophyView official trial listing → -
Completed NCT NCT04952051
Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 1000 participants Est. completion 2020-07-01 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT04954196
Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index
Not yet reported University Hospital, Montpellier Est. completion 2024-09-08 Stand-aloneOther conditions: Frozen Embryo TransferView official trial listing → -
Status unknown NCT NCT04962841
Nutraceuticals and Drug Treatment in Frail Older Adults
University of Campania Luigi Vanvitelli 485 participants Est. completion 2023-04-01 1 siteOther conditions: FrailtyView official trial listing → -
Withdrawn NCT NCT04978649
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy
Not yet reported Guangdong Provincial People's Hospital Est. completion 2028-07-31Type 2 diabetes Other conditions: Blood PressureView official trial listing → -
Status unknown NCT NCT05077462
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers
Not yet reported AJU Pharm Co., Ltd. 60 participants Est. completion 2022-04-30 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT05077475
A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers
Not yet reported AJU Pharm Co., Ltd. 60 participants Est. completion 2022-04-30 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT05103332
Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)
Not yet reported Alnylam Pharmaceuticals 663 participants Est. completion 2024-09-13 110 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT05144360
Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension
Not yet reported EMS Est. completion 2024-11 Stand-aloneOther conditions: Hypertension Associated, Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT05155436
Occurrence of Dyskalemia With Treatment for Hypertension
Not yet reported National Heart Foundation of Bangladesh 1090 participants Est. completion 2023-03-31 1 site Stand-aloneOther conditions: Hypertension, Potassium ImbalanceView official trial listing → -
Status unknown NCT NCT05165251
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
Not yet reported Shanghai Jiao Tong University School of Medicine 480 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: Isolated Systolic HypertensionView official trial listing → -
Not yet recruiting NCT NCT05169021
Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD
Not yet reported Beijing Tiantan Hospital 15000 participants Est. completion 2028-12-31 1 siteCardiovascular disease Other conditions: Cerebral Small Vessel DiseasesView official trial listing → -
Status unknown NCT NCT05173025
Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
Not yet reported Seoul National University Bundang Hospital 42 participants Est. completion 2023-12-31 1 siteType 2 diabetes Other conditions: Hypertension, Atherosclerosis, Renin HypertensionView official trial listing → -
Completed NCT NCT05189015
Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
Not yet reported Seoul National University Bundang Hospital 80 participants Est. completion 2023-06-30 1 siteType 2 diabetes Other conditions: Angiotensin/Renin/Aldosterone Hypertension, HypertensionView official trial listing → -
Status unknown NCT NCT05212597
Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB
Not yet reported Samsung Medical Center 100 participants Est. completion 2024-12 1 siteOther conditions: Aortic Valve InsufficiencyView official trial listing → -
Status unknown NCT NCT05259020
To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers
Not yet reported IlDong Pharmaceutical Co Ltd 60 participants Est. completion 2022-03-30 1 site Stand-aloneOther conditions: Dyslipidemias, HypertensionView official trial listing → -
Withdrawn NCT NCT05275907
Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)
Not yet reported Northwestern University Est. completion 2023-10-04 1 siteOther conditions: High Blood Pressure, Liver Transplant, Renal Function AbnormalView official trial listing → -
Completed NCT NCT05279807
Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each Monotherapy
Not yet reported Menarini International Operations Luxembourg SA 277 participants Est. completion 2022-04-28 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT05288400
Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.
Not yet reported Servier 150 participants Est. completion 2018-12-18 15 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Active, not recruiting NCT NCT05331144
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
Not yet reported Rong Zhang 180 participants Est. completion 2028-08-31 1 site Stand-aloneOther conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of DementiaView official trial listing → -
Terminated NCT NCT05370599
Hypertension in Young Adults Trial
Not yet reported University of California, San Francisco 36 participants Est. completion 2026-01-07 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT05377203
Low-dose Quadruple Combination Therapy in Patients With Hypertension
Not yet reported The Third Xiangya Hospital of Central South University 90 participants Est. completion 2023-07-04 1 site Stand-aloneOther conditions: Hypertension, Arterial HypertensionView official trial listing → -
Status unknown NCT NCT05398393
An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150 participants Est. completion 2023-06-30 1 siteOther conditions: Hepatitis B, Chronic, Lipid DisorderView official trial listing → -
Not yet recruiting NCT NCT05416840
Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension
Not yet reported Jing Liu 92 participants Est. completion 2026-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT05450575
An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
Hanmi Pharmaceutical Company Limited 5400 participants Est. completion 2021-07-20 1 siteOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT05462535
An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet
Hanmi Pharmaceutical Company Limited 4785 participants Est. completion 2021-07-15 1 siteOther conditions: Hypertension,EssentialView official trial listing → -
Completed NCT NCT05467384
Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients
Not yet reported Ayub Teaching Hospital 80 participants Est. completion 2017-06-30 Stand-aloneOther conditions: Hypercholesterolemia, Hypertension, Cholesterol DepositionView official trial listing → -
Completed NCT NCT05470764
Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers
Not yet reported Darnitsa Pharmaceutical Company 52 participants Est. completion 2021-06-28 1 site Stand-aloneOther conditions: Bioequivalence, Healthy SubjectsView official trial listing → -
Completed NCT NCT05475665
Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
Not yet reported Handok Inc. 157 participants Est. completion 2023-06-13 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT05476354
Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
Not yet reported Handok Inc. 271 participants Est. completion 2023-06-13 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT05479097
Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage
Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2023-12-31 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT05513937
Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy
Not yet reported Menarini International Operations Luxembourg SA 301 participants Est. completion 2022-11-15 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT05545059
Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 138 participants Est. completion 2023-03-31 1 site Stand-aloneOther conditions: Resistant HypertensionView official trial listing → -
Status unknown NCT NCT05552300
Superselective Adrenal Arterial Embolization for Resistant Hypertension
Not yet reported First Affiliated Hospital of Chengdu Medical College 144 participants Est. completion 2025-03-31 Stand-aloneOther conditions: Resistant HypertensionView official trial listing → -
Completed NCT NCT05609513
Integration of Hypertension Management in HIV Care in Uganda
Not yet reported Infectious Diseases Research Collaboration, Uganda 87421 participants Est. completion 2025-10-03 16 sites Stand-aloneOther conditions: HIV/AIDS, HypertensionView official trial listing → -
Active, not recruiting NCT NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
Daewoong Pharmaceutical Co. LTD. 4000 participants Est. completion 2025-12-31 1 siteOther conditions: Hypertension, DyslipidemiasView official trial listing → -
Completed NCT NCT05663073
Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers
Not yet reported Handok Inc. 46 participants Est. completion 2023-04-21 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT05667818
An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions
Not yet reported Overseas Pharmaceuticals, Ltd. 16 participants Est. completion 2023-03-10 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT05679102
Atorvastatin as an Antihypertensive Agent
Not yet reported Himayat Ullah 120 participants Est. completion 2023-01-04 1 siteOther conditions: Atorvastatin Antihypertensive EffectView official trial listing → -
Completed NCT NCT05683301
Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India
Not yet reported Centre for Chronic Disease Control, India 1981 participants Est. completion 2024-09-22 35 sites Stand-aloneOther conditions: Primary HypertensionView official trial listing → -
Completed NCT NCT05688085
Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers
Not yet reported Handok Inc. 44 participants Est. completion 2023-04-21 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT05688098
Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers
Not yet reported Handok Inc. 44 participants Est. completion 2023-04-21 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT05764317
Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)
Servier Russia 409 participants Est. completion 2024-02-20 1 siteOther conditions: Arterial Hypertension, HTNView official trial listing → -
Completed NCT NCT05808725
Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
Not yet reported Brillian Pharma Inc. 24 participants Est. completion 2023-04-17 1 site Stand-aloneCardiovascular disease Other conditions: HypertensionView official trial listing → -
Completed NCT NCT05820880
Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension
Not yet reported Institut de Recherches Internationales Servier 532 participants Est. completion 2022-02-23 42 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT05843162
A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Not yet reported Chong Kun Dang Pharmaceutical 116 participants Est. completion 2023-12-31 Stand-aloneMetabolic syndrome Other conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT05893849
Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults
Peking University Third Hospital 624 participants Est. completion 2024-04 1 siteOther conditions: AgingView official trial listing → -
Status unknown NCT NCT05899920
Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy
Not yet reported Ryazan State Medical University 190 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Resistant Arterial HypertensionView official trial listing → -
Status unknown NCT NCT05917275
Multi-Omics to Predict the Blood Pressure Response to Antihypertensives
Not yet reported Radboud University Medical Center 96 participants Est. completion 2025-10 1 site Stand-aloneOther conditions: Primary HypertensionView official trial listing → -
Completed NCT NCT05920005
Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension
Not yet reported Hospital Israelita Albert Einstein 702 participants Est. completion 2025-05-01 22 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT05940909
Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions
Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-11-17 1 siteOther conditions: BioequivalenceView official trial listing → -
Status unknown NCT NCT05954884
Community-based HEARTS Intervention (Pilot)
Not yet reported National Heart Foundation of Bangladesh 400 participants Est. completion 2025-03-31 Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT05976438
Skin Sodium and Salt Sensitivity of Blood Pressure
Not yet reported Cambridge University Hospitals NHS Foundation Trust 60 participants Est. completion 2024-12 2 sitesOther conditions: HypertensionView official trial listing → -
Not yet recruiting NCT NCT06012487
Correlates and Control of Blood Pressure Variability
Not yet reported Cedars-Sinai Medical Center 10 participants Est. completion 2026-12-31Other conditions: Blood Pressure VariabilityView official trial listing → -
Active, not recruiting NCT NCT06041529
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
Not yet reported Yuhan Corporation 198 participants Est. completion 2026-02-28 15 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT06130124
S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement
Hanlim Pharm. Co., Ltd. 5000 participants Est. completion 2025-07-25 1 siteOther conditions: Essential HypertensionView official trial listing → -
Status unknown NCT NCT06164379
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
Not yet reported Shanghai Jiao Tong University School of Medicine 150 participants Est. completion 2024-12-16 1 site Stand-aloneOther conditions: Primary AldosteronismView official trial listing → -
Status unknown NCT NCT06193044
Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets
Not yet reported International Bio service 48 participants Est. completion 2024-07-12 Stand-aloneOther conditions: Healthy VolunteerView official trial listing → -
Completed NCT NCT06212648
Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 253 participants Est. completion 2023-01-27 1 site Stand-aloneOther conditions: Hypertension, Essential HypertensionView official trial listing → -
Status unknown NCT NCT06214832
An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)
Hanlim Pharm. Co., Ltd. 4000 participants Est. completion 2025-08-30 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT06236061
Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Not yet reported Novartis Pharmaceuticals 718 participants Est. completion 2025-12-23 43 sites Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT06259175
Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)
Servier Russia 396 participants Est. completion 2025-06-01 1 siteOther conditions: Arterial Hypertension, HTNView official trial listing → -
Status unknown NCT NCT06275763
Optimal Medical Treatment of Difficult-to-treat Hypertension
Not yet reported National Institute of Cardiology, Warsaw, Poland 2500 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Not yet recruiting NCT NCT06282107
Effectiveness and Safety of BiSAAE for Resistant Hypertension.
Not yet reported First Affiliated Hospital of Chengdu Medical College 72 participants Est. completion 2026-12-31 Stand-aloneOther conditions: Resistant HypertensionView official trial listing → -
Active, not recruiting NCT NCT06282549
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension
Yuhan Corporation 1219 participants Est. completion 2027-03-31 5 sitesOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT06293261
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
Yuhan Corporation 5047 participants Est. completion 2024-03-31 39 sitesOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT06366386
Integrating Hypertension Management in DSD for HIV
Infectious Diseases Research Collaboration, Uganda 1100 participants Est. completion 2026-05-30 1 siteOther conditions: Hypertension, HIVView official trial listing → -
Completed NCT NCT06395194
Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
Not yet reported Oslo University Hospital 15313 participants Est. completion 2003-12-05Other conditions: Essential HypertensionView official trial listing → -
Not yet recruiting NCT NCT06460896
Analysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs
Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2027-09 1 siteOther conditions: Bypass Bariatric SurgeryView official trial listing → -
Completed NCT NCT06465264
To Assess Allisartan Isoproxil/Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil
Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 499 participants Est. completion 2023-02-24 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT06487949
Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
Not yet reported Shiraz University of Medical Sciences 114 participants Est. completion 2023-12-01 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT06515678
Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension
Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sitesOther conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, HypertensionView official trial listing → -
Status unknown NCT NCT06618079
Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B
Not yet reported Huons Co., Ltd. 46 participants Est. completion 2024-10-01 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Enrolling by invitation NCT NCT06646354
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
Not yet reported Hyundai Pharm 125 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Hypertension, Primary HypercholesterolaemiaView official trial listing → -
Completed NCT NCT06704815
Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.
Servier Affaires Médicales 400 participants Est. completion 2024-06-12 1 siteOther conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT06713785
Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension
Not yet reported Queen Mary University of London Est. completion 2021-05-31Other conditions: HypertensionView official trial listing → -
Withdrawn NCT NCT06730945
Effect of Oral Isosorbide Mononitrate Plus Amlodipine Antispasm Therapy on Outcomes of Radial Artery Grafts After CABG
Not yet reported Ruijin Hospital Est. completion 2030-12 1 site Stand-aloneOther conditions: Coronary Artery Bypass Graft Surgery (CABG), Radial Artery Grafts, Graft FailureView official trial listing → -
Not yet recruiting NCT NCT06771245
A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606 participants Est. completion 2026-10-30Other conditions: Mild-to-moderate Essential HypertensionView official trial listing → -
Not yet recruiting NCT NCT06780865
Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension
Not yet reported Shanghai Institute of Hypertension 200 participants Est. completion 2028-12-31 Stand-aloneChronic kidney disease Other conditions: Nocturnal HypertensionView official trial listing → -
Not yet recruiting NCT NCT06790927
Standardized Antihypertensive Treatment Protocol
Not yet reported Shanghai Jiao Tong University School of Medicine 400 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Not yet recruiting NCT NCT06796660
Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients
Not yet reported Liu Zhanghong 70 participants Est. completion 2027-12-31 3 sites Stand-aloneOther conditions: Renal Insufficiency, ChronicView official trial listing → -
Not yet recruiting NCT NCT06942377
Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy
Not yet reported Peking University People's Hospital 140 participants Est. completion 2027-12-01 1 site Stand-aloneOther conditions: Endometrial CancerView official trial listing → -
Enrolling by invitation NCT NCT07064525
Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension
Not yet reported Shin Poong Pharmaceutical Co. Ltd. 252 participants Est. completion 2026-02-28 1 siteHeart failure Other conditions: Hypertension (HTN), Diabete MellitusView official trial listing → -
Not yet recruiting NCT NCT07075965
Calcium Channel Blocker in Myotonic Dystrophy Type 1
Not yet reported University of Rochester 20 participants Est. completion 2030-10-01 Stand-aloneOther conditions: Myotonic Dystrophy 1View official trial listing → -
Completed NCT NCT07116863
A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension
Not yet reported Kyungdong Pharmaceutical Co., Ltd. 286 participants Est. completion 2024-09-13 2 sites Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Not yet recruiting NCT NCT07232966
Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension
Not yet reported Yan Li 220 participants Est. completion 2029-06-30 1 site Stand-aloneOther conditions: Resistant HypertensionView official trial listing → -
Not yet recruiting NCT NCT07240909
Antihypertensive Drug Selection Based on Hemodynamic Phenotypes
Not yet reported The Third Xiangya Hospital of Central South University 240 participants Est. completion 2026-12 Stand-aloneOther conditions: HypertensionView official trial listing → -
Not yet recruiting NCT NCT07241338
Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity
Not yet reported Jing Liu 104 participants Est. completion 2027-06 1 siteOther conditions: HypertensionView official trial listing → -
Not yet recruiting NCT NCT07262710
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19Cardiovascular diseaseView official trial listing → -
Not yet recruiting NCT NCT07291375
Role of Amlodipine in Reduction of CIN
Not yet reported Minia University 40 participants Est. completion 2026-07-01Other conditions: Contrast-induced NephropathyView official trial listing → -
Completed NCT NCT07327749
Comparing Bisoprolol and Valsartan-Amlodipine for Hypertension
Not yet reported Shiraz University of Medical Sciences 59 participants Est. completion 2025-12-12 1 siteOther conditions: HypertensionView official trial listing → -
Completed NCT NCT07436104
Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.
Not yet reported MAHAN Trust 72564 participants Est. completion 2023-08-31 1 site Stand-aloneOther conditions: Hypertension (HTN), Diarrhea, Pneumonia, Malaria Fever, COPD, Asthma (Diagnosis), Diarrhea ChronicView official trial listing → -
Not yet recruiting NCT NCT07486453
Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets
Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 60 participants Est. completion 2026-04-25 1 site Stand-aloneOther conditions: Primary HypertensionView official trial listing → -
Completed NCT NCT07564726
Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol
Not yet reported Celltrion Pharm, Inc. 163 participants Est. completion 2024-02-13 21 sites Stand-aloneOther conditions: Hypertension, HypercholesterolemiaView official trial listing → -
Not yet recruiting NCT NCT07618806
A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women With Mild High Blood Pressure.
Not yet reported Zentiva, k.s. 344 participants Est. completion 2028-05-31 Stand-aloneOther conditions: Hypertension, OedemaView official trial listing → -
Not yet recruiting NCT NCT07687160
SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy
Not yet reported Ottawa Hospital Research Institute 30 participants Est. completion 2028-02 4 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT07704684
Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine
Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 376 participants Est. completion 2025-09-08 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT07704697
Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/Allisartan
Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 346 participants Est. completion 2025-11-24 1 site Stand-aloneOther conditions: Essential HypertensionView official trial listing → -
Active, not recruiting NCT NCT07847970
VITAL: Real-World Evaluation of Amlodipine/Valsartan.
VIVA PHARM LLP 216 participants Est. completion 2026-11-20 18 sitesCardiovascular disease Other conditions: HypertensionView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Amlodipine Besylate, Amlodipine and Benazepril Hydrochloride, Amlodipine and Olmesartan Medoxomil, Amlodipine, Amlodipine 5mg, Qiaohean
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
